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FINAL REPORT 4 
Executive Summary 
 KPMG LLP (KPMG) was engaged by the Global Health Research Initiative (GHRI or the 
‘Initiative’) via the International Development Research Centre (IDRC) to undertake a 
Review of the GHRI on behalf of the five departments/agencies which have partnered via a 
memorandum of understanding (MOU) to support the Initiative. 
The review of GHRI was initiated as a result of the requirement that the relevance and 
merit of the GHRI partnership arrangement be reviewed every three years as stated in the 
MOU.  The last external review was completed in 2006.  A number of questions raised by 
the GHRI Steering Committee regarding the relevance, performance, and governance of 
GHRI were summarized into the following eight questions to be addressed by the current 
Review: 
Relevance 
1. Is the GHRI relevant and what merits does the partnership arrangement possess? 
2. Is there an on-going need for GHRI? 
 
Performance & Results 
3. What progress has been made since 2006?  
4. What impact has the Initiative achieved? 
5. Does the partnership provide value-added that would not be possible if the partners 
acted independently in this area? 
 
Governance & Model  
6. How has the overarching MOU and partnership composition worked? 
7. Is GHRI the right model?  
8. Are there comparable models that may provide lessons or insight into possible 
alterations? 
This report presents the Review key findings, analysis, and recommended options to 
enhance the Initiative from the perspective of relevance, performance, results, governance 
and the partnership model.   The scope of this Review was contained to the 8 Review 
questions noted above and the following Review methods: a review of available relevant 
GHRI documentation; interviews with GHRI staff (4) GHRI Steering Committee members 
(11), other Canadian government department/agency representatives (8), GHRI external 
stakeholders (7), and GHRI funded Canadian and LMIC researchers (6); and a comparison 
of GHRI’s model to that of 3 other international organizations including interviews with 
their representatives. 
As a result of the information gathered and analyzed, it is apparent that there is valid 
reasoning for the rationale behind Canada’s Global Health Research Initiative.  There 





opportunities for researchers to build the global health research area across many different 
facets (knowledge creation, capacity building, knowledge translation) and across many 
different disciplines.  GHRI is a unique model in its partnerships between Canadian 
researchers, low- and middle-income country researchers and research users.  GHRI is seen 
as a critical enabler in the establishment of global health research programs.  Despite this, 
many interviewed key informants indicated that if GHRI is to remain relevant, needed, and 
supported, there is a requirement for change and/or enhancement.   
Seen as a relevant and key contributor to Canada’s commitment to addressing global health 
issues, GHRI is aligned to the mandates of the partner departments/agencies and is viewed 
as an integrated “whole of Canada” approach to global health research.  Higher visibility 
and an enhanced image on matters pertaining to global health and global health research 
have been reported for Canada and the participating departments, nationally and 
internationally.  This said, there is opportunity for enhanced clarity and alignment between 
the GHRI mandate and priorities and the priorities of each partner department/agency. 
Further, opportunities exist to better define priorities and related expected outcomes among 
partners and increase visibility and connection to internal and external stakeholders. The 
model enables global health research related dialogue among five departments/agencies in 
a structured and focused manner that would likely not otherwise be possible.  Pooled 
funding and the integrated partner approach have resulted in a stronger investment in 
global health research.  Although, it was clear this investment could be further strengthened 
by increasing efforts to develop key strategic external relationships with other synergistic 
organizations. 
There are healthy discussions taking place through the Steering Committee allowing GHRI 
to draw upon each partner’s strengths and areas of expertise, such as the management of 
international research projects by IDRC and the leading practices for scientific peer review 
from CIHR, contributing to efficiencies gained for all partners involved.   
GHRI is making progress in its stated strategic directions and the research projects 
supported through the Initiative are producing impacts.  Research capacity in Canada and 
low- and middle-income countries has increased.  Increased opportunities, credibility of 
programs, and growth in relationships, networks and collaborations have contributed to 
growth and/or expansion of research programs.  However, increased levels of “knowledge 
brokering” of research results to partners and other stakeholders (and potential 
stakeholders) would improve progress and the potential for additional impacts.   
There are some outstanding issues that are affecting, and will continue to affect, the 
progress and impacts that GHRI may achieve.  Some of these were identified as limitations 
in the previous reviews of GHRI conducted in 2006.   
The most fundamental is the elucidation of the partnership.  Clarity of roles, 
responsibilities, value propositions, common priorities and individual contributions and 
expected returns is a key foundational element that partners and the partnership are 
missing.  Heightening this is the current ad hoc funding model and operation in “reaction” 
to availability of funds and attachment to specific departmental mandates was thought to 
potentially restrict growth and advancement of the initiative.  It was felt GHRI impacts 
may be greater if more flexibility was built into the funding model.  As well, there is some 
“tenderness” surrounding unequal research funding contributions by partners.   
Governance issues were also identified.  Increased visibility for GHRI at senior levels 





ways is required to drive consensus around strategy and priorities for the Initiative.  
Additionally, the membership of the GHRI Steering Committee was not seen to be 
consistent with the senior level requirement needed to meet the accountabilities of such a 
decisive and influential group.  Operational activities now undertaken by the Steering 
Committee are taking away from the critical strategic role necessary to move forward. 
Overall, since the last review completed in 2006, GHRI has sustained its positive 
influences including its good reputation, impact to global health research community, and 
increased awareness of global health research benefits among partners.  It is an important 
addition to Canada’s approach to global health.  After 10 years of operation, this is an 
appropriate time to look at refining its model to help ensure its long-term relevance and to 
maximize the value GHRI can deliver and/or help enable. 
Overall, it appears that GHRI is making progress in its stated strategic areas and the 
research projects supported through the Initiative are producing impacts.  It is also clear 
that researchers themselves and the Canadian global health research landscape would be 
negatively impacted should GHRI not continue.  Not renewing the Initiative could increase 
the risk of partners perhaps working at cross-purpose and a gap would be created in the 
global health systems research area. In effect, this is not seen to be a practical option at this 
time – unless of course an alternative mechanism or set of mechanisms was established to 
enable the progress made to date via GHRI to be leveraged and furthered through some 
other means.  Consideration has been given by some interviewed key informants regarding 
the possibility of similar initiatives and progress being made possible via bilateral 
agreements. While this may be the case, some interviewed internal and external key 
informants believe this would diminish the impacts to be made and would weaken 
Canada’s position/image internationally as being integrated in its global health research 
efforts.   
This said, however, it is clear based on the summary of findings and the international 
comparative review presented in this report, that status quo is not a viable option either.  
This is because there are some very fundamental areas that still require solidification, for 
example, a common understanding among partners as to what each partner brings to the 
table (including committed funding), the establishment of common priorities and what 
outcomes the GHRI is aiming to achieve.  There are also other areas that could be pursued 
now that GHRI has matured as an organization.  The exploration of strategic relationships 
with external organizations and the upcoming opportunity to make further use of research 
and performance indicators now that the projects are further along in their work plans are a 
few examples.  Opportunities do exist for the partners to enhance the GHRI.   
Some key informants felt consideration could be given to establishing the GHRI as a “true” 
horizontal initiative with a separate program budget.  According to Treasury Board, a 
horizontal initiative is an initiative in which partners from two or more organizations have 
established a formal funding agreement (e.g., Memorandum to Cabinet, Treasury Board 
Submission, federal/provincial agreement) to work toward the achievement of shared 
outcomes. The Office of the Auditor General (OAG 2005)1 recognizes that horizontal 
initiatives are generally a reflection that an issue is complex and can be dealt with most 
effectively by coordinated actions across departments of government.  This definition 
certainly fits with the GHRI however, with the transformation considerations noted below, 
                                                     
1 Office of the Auditor General (2005), Matters of Special Importance – 2005, Chapter 4, “Managing 





GHRI should be able to achieve the benefits of such coordinated efforts without the 
administration and energy required to establish such a formal program. 
 
As a result of the information gathered and insight gained through documentation review 
and key informant interviews regarding the current relevance, performance, results, 
governance and model surrounding GHRI, it has become apparent that opportunity does 
exist to enhance the future value, performance, effectiveness, and impact of GHRI through 
modest yet meaningful transformation.   
It is believed that the transformation considerations presented below are within GHRI’s 
ability and control to implement provided the Secretariat and Steering Committee share a 
common vision on the desired change and maintain a shared commitment to planning, 
implementing, and sustaining the change.  Buy-in and commitment from all partner 
organizations will be essential for success. 
The planning and execution of the suggested change will require focus and dedication on 
the part of the Secretariat. To reduce the impact the effort will have on existing resources 
and minimize the degree of disruption on current Secretariat operations, consideration 
should be given to securing a resource for a defined period of time to work with the 
Secretariat and Steering Committee to plan, design, and implement the transformative 
change.  This individual could be seconded from one of the partner organizations or be 
secured via contract from the consulting community.  
Recommended key transformation considerations include, but may not be limited to, the 
following: 
1 Clearer and more deliberate alignment of partner departmental/agency priorities and 
GHRI’s mission and priorities with the focus being on how GHRI can and will assist 
partner departments/agencies fulfill and/or enable fulfillment of their mandates and 
priorities.  
2 Formalization of a GHRI strategic plan complete with such key aspects as: vision; 
mission; values; strategic priorities/directions; strategic outcomes to be achieved; and 
action plans for each strategic priority/direction.2 
3 Formation of well defined strategic alliances with organizations and/or initiatives 
outside of the five partner departments/agencies which may be synergistic to what 
GHRI is striving to achieve.   Explore all avenues for collaboration with other 
Canadian and/or international organizations, private/ public partnerships, industry, 
academia, research institutions, and non-government organizations.  This practice, 
supported by the International Review and the key informant interviews, identifies 
benefits to scaling-up funding capacity which in turn provides advantages to funders, 
researchers and the targeted sector.  Such alliances should be clearly defined and 
agreed to by all parties and should include at a minimum:  intent of the alliance; 
degree and type of collaboration/coordination; specific and measurable strategic 
outcomes to be achieved; role and obligations of all parties in realizing defined 
strategic outcomes; and an agreed to process for measuring and reporting on results 
achieved and/or issues encountered. 
                                                     





4 Clear articulation, documentation and agreement on what each partner organization’s 
contribution will be to the partnership and Initiative.  This should include specific, 
measurable, achievable, relevant, and time-bound actions and contributions.  
Consideration should be given to both monetary and non-monetary contributions as 
both may be needed and of value.    
5 Renewal of the existing MOU to include more detailed articulation of: 1) why each 
of the five partner organizations is in the partnership, i.e., clear articulation of how 
GHRI participation will support and/or enable achievement of departmental/agency 
mandates and priorities; and 2) what meaningful and measurable contribution each 
partner organization will make to the GHRI partnership.  
6 Renewal of the GHRI management and governance regime so as to strengthen the 
value derived from and better delineate between the roles, accountabilities, and 
responsibilities of the Secretariat versus those of the Steering Committee.  Leading 
practices gleaned from the international comparator organizations and mentioned by 
key informant interviews lead to a requisite review of this area.  In so doing, 
consideration should be given to: 
- Examining the current focus and activities of the current governing body, i.e., 
the Steering Committee, to determine which areas of focus, activities and/or 
decisions made are more operational and/or tactical in nature and, therefore 
could/should be delegated to the Secretariat thus positioning the Steering 
Committee to focus exclusively on matters of strategic direction in 
collaboration with the Secretariat and provision of oversight to the Initiative. 
 
- Examining the membership of the existing Steering Committee and determine 
if the composition is optimal.  This could/should include consideration of 
such key aspects as: the seniority of each member, within their respective 
organizations, to provide strategic direction and oversight for GHRI; the  
level of authority and accountability he/she has within his/her home 
department/agency to make recommendations and decisions concerning 
GHRI; his/her ability to raise the visibility and awareness of GHRI within 
their home organization; and the relevance of each member’s position and 
organizational placement within their home department/agency and alignment 
of organization unit mandate and priorities and those of GHRI.  Strong 
oversight is critical to being able to provide balanced, cohesive and focussed 
direction and being able to represent/ balance the needs and interests of all 
partners and other interested parties and/or strategic alliances.   
 
- Considering the establishment of a two tiered governance structure whereby 
an Executive Strategic Advisory Committee is created and attended by 
partner department/agency ADMs and VPs. This could help elevate the 
awareness, interest and understanding of GHRI within and across all partner 
organizations and would potentially bring additional strategic insight and 
advice to GHRI thus potentially strengthening the alignment with 
departmental/agency priorities, GHRI relevance, and value to be derived 
through the Initiative. As well, it could help drive increased awareness and 
potential involvement on the part of Heads of Agency.  To manage the time 
demand this would place on members, consideration should be given to 





ensure there is clear delineation between the role and accountabilities of this 
Committee and that of Steering Committee which could be rebranded as the 
Governance Committee. 
 
- Considering the inclusion of ex-officio members on the Executive Strategic 
Advisory Committee and/or Steering Committee/Governance Committee.  
Such members could be individuals from organizations outside of the existing 
partnership which are or may be synergistic.  This could include 
representatives from organizations with whom GHRI forms strategic alliances 
as suggested above.  This would establish a link with such organizations 
which may result in future and mutually beneficial collaborations and/or 
expansion of the reach and impact that can be made by GHRI. To limit the 
time burden on ex-officio members and raise the value GHRI will receive 
through their involvement, it is suggested that consideration be given to what 
discussions/type of discussions these individuals would be asked to 
participate in. For example, it may be only those meetings where strategic 
direction, priorities, collaborations, research programs are being discussed. 
 
7 Exploration of how GHRI via the partnership and Secretariat can be positioned 
beyond the role of ‘implementer’ to also be that of ‘a catalyst’ for forward thinking 
on matters pertaining to global health research and Canada’s involvement in terms of 
knowledge creation, capacity building and/or knowledge translation, and ‘knowledge 
broker’ between and among Initiative partners, strategic alliances, and other 
interested parties both domestically and internationally. As a starting point, this 
could include bringing key stakeholders together, facilitating and ‘holding the pen’ 
on the development of an integrated Government of Canada vision and strategy for 
global health research. 
8 Renewal of how GHRI documents contributions being made over time, what and 
how outcomes have been/will be achieved, and how these factors as well as overall 
progress and impacts will be monitored and reported on and to whom.  Within this 
context, consideration should be given to making use of existing tools, drawing on 
advantages of proven methods (i.e., leverage partner department experiences) and 
from the International Review, include different areas of measurement to fully assess 
performance of the whole Initiative (e.g., progress on research projects, as well as 
internal management performance, impacts to partners, etc.)  Each partner must see 
itself within the framework of outputs and outcomes/impacts.   This will help enable 
more focused and consistent measurement of GHRI performance.   
How GHRI wishes to pursue the above recommended transformation considerations should 
be explored and decided up jointly by the Secretariat, Steering Committee and Heads of 
Agency.  It is recommended that this be incorporated into or aligned with the planned 
upcoming Strategic Planning initiative. Further, it is recommended that consideration be 
given to engaging an independent and experienced facilitator to lead stakeholders through 
the process in a robust and systematic manner.  This will be important to help ensure the 
right questions get asked – including the most difficult and sensitive ones, the right people 
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I. Introduction 
KPMG LLP (KPMG) was engaged by the Global Health Research Initiative (GHRI or the 
‘Initiative’) via the International Development Research Centre (IDRC) to undertake a 
Review of the GHRI on behalf of the five departments/agencies which have partnered via a 
memorandum of understanding (MOU) to support the Initiative. 
A. Background 
The review of GHRI was initiated as a result of a requirement to have an independent 
review of the relevance and merit of the GHRI partnership arrangement every three years 
as stated in the MOU.  The last external review was completed in 2006.  A number of 
questions raised by the GHRI Steering Committee regarding the relevance, performance, 
and governance of GHRI were summarized into the following eight questions to be 
addressed by the current Review. 
Exhibit 1 
Questions to be addressed in the review 
Relevance 
9. Is the GHRI relevant and what merits does the partnership arrangement possess? 
10. Is there an on-going need for GHRI? 
 
Performance & Results 
11. What progress has been made since 2006?  
12. What impact has the Initiative achieved? 
13. Does the partnership provide value-added that would not be possible if the partners 
acted independently in this area? 
 
Governance & Model  
14. How has the overarching MOU and partnership composition worked? 
15. Is GHRI the right model?  
16. Are there comparable models that may provide lessons or insight into possible 
alterations? 
 
B. Review objectives  
The objectives of the GHRI Review were as follows. 
 
1. To assist the five partnering agencies/departments in their examination of the progress 
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2. To support decision-making by partnering agencies/departments on renewal. 
 
3. To identify and summarize the effectiveness of the GHRI in achieving its mandate. 
 
4. To identify and summarize the key strengths and weakness of the GHRI approach and 
the value of the Initiative to each of the partners. 
 
5. To gain insights and lessons learned relating to possible improvements, prioritization 
and focus in support of renewal for the GHRI.  
 
 
C. Review scope & approach 
The scope of the Review has been contained within the eight Review questions presented 
above in Exhibit 1.  Combined, these questions will address the five objectives presented 
above in Section B.  
 
There were three principal methods of data collection required for the Review:  (1) key 
informant interviews; (2) document review; and (3) international comparative review.  
1. Key Informant Interviews 
A listing of key informant interviewees was developed by the GHRI Secretariat with input 
and approval from the GHRI Steering Committee.  The mix of interviewees included a 
combination of internal and external GHRI stakeholders and three international informants.  
When selecting interviewees, it is our understanding that the primary focus was on 
selecting individuals who: are knowledgeable about GHRI; are currently or have in the past 
been involved in GHRI directly or indirectly; are associated with complementary 
organizations/programs; and/or are associated with complementary or comparative 
organizations internationally.   
 
A total of 39 interviews were undertaken with the following respondent groups: 
Key informant interview groups Number of 
interviewees 
Internal 
 GHRI staff 
 GHRI Steering Committee members 







 GHRI stakeholders (broadly within the 
Global Health Research area) 
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Total 39 
a)  Internal interviews 
Representatives of the GHRI Secretariat, the GHRI Steering Committee, other 
representatives from the partner departments/agencies as well as other representatives from 
Canadian Government Departments/Agencies were interviewed by telephone or in-person.  
The interviews with GHRI Secretariat and Steering Committee representatives addressed 
all review questions.  The interviews with other government representatives mainly 
focused on relevance and the partnership, but still addressed governance and progress at a 
high level.  Twenty three representatives of these groups were formally interviewed.  
b)  External interviews 
Representatives of external GHRI stakeholders (i.e., other Canadian initiatives and 
networks focused on global health issues), a limited selection of GHRI researchers 
(Canadian and LMIC researchers receiving funding), and a selection of International 
representatives of similar organizations were interviewed by telephone.  The interviews 
with external GHRI stakeholders and GHRI researchers focused on relevance, progress, 
impacts and lessons learned.  The interviews with other international jurisdictions were in 
support of the organizational comparative review (see section 3 below).  Thirteen 
representatives of these groups were formally interviewed (one LMIC researcher provided 
a written response).  
The interview guides used for the different respondent groups in both the internal and 
external interviews are included in Appendix A. 
2.  Document Review 
A review of supporting documentation relating to the GHRI’s design, delivery and results 
achieved was completed.  Certain data derived from the document review have been 
incorporated throughout this report as part of the analysis.  Types of documents reviewed 
included:  GHRI annual reports; governance framework; performance reports; external 
performance reviews; Steering Committee meeting minutes; and planning documents. 
3.  International Comparative Review 
 
A high-level review of the characteristics of international initiatives sharing similarities to 
various elements of the GHRI to identify possible lessons learned or best/better practices 
was undertaken.  This work did draw from, and build, on prior efforts undertaken by GHRI 
with regard to identifying possible comparators and summarized in the document “Global 
Health Research Funders (Canada and International)—Web scan information”, developed 
in support of a Steering Committee Planning Day held in April of 2010  Our review of the 
approaches in three selected jurisdictions consisted of a review of information on the 
selected organizations’ websites plus follow-up contacts with representatives of these 
organizations, where possible. 
 
The jurisdiction/initiatives selected for review summarize organizational characteristics 
describing structure, budgets, governance, research priorities, and delivery aspects.  
Jurisdictions selected for review were intended to share similarities with various elements 
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criteria elements were taken into consideration when researching potential 
organizations/initiatives: 
 
1. Must be partnership or collaboration between two or more organizations 
2. Must be publicly funded (at least in part) 
3. Focused on needs of both home country and LMICs 
4. Must undertake global health systems research activities. 
 
The following table identifies the initial results for those jurisdictions/initiatives 
researched.   
 
Jurisdiction/initiative Criteria element  
Pros 






 Large partnership between 
EU countries, Switzerland, 
Norway and sub-Saharan 
Africa. 
 Focus on capacity building 
and clinical trials 
 Process to identify 
complementary priority 
areas for partnerships 
 Large projects (1-5 years) 
 KPIs in place 
 Secretariat or equivalent in 
place 
 May be too large 
 Based on existing 
research activities 
 More oriented to 
biomedical 
 Narrow scope:  Sub-
Saharan Africa, 
HIV/AIDS, TB and 
malaria 
 Some co-funding 
requirements 
The Research Council of 
Norway (RCN) 
Global Health and 
Vaccination Research 
 At same “fork in road” as 
GHRI, may have collected 
lessons learned 
 Overall RCN is funded by 
several Ministries 
 One program run under one 
government department 
 International Partnerships 
 Focused on strengthening 
capacity in Norway and 
LMICs  
 62 projects funded since 
2005 (comparable to GHRI 
at approx. 54)) 
 Secretariat or equivalent in 
place 
 Currently in negotiations 
to extend funding beyond 
2011 
 Has only published two 
calls for proposals 
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Jurisdiction/initiative Criteria element  
Pros  
Criteria element  
Cons  
World Health 
Organization – Special 
Programme for Research 
and Training in Tropical 
Diseases (WHO-TDR) 
 Multiple funders, 
public, private, not-for-
profit 
 Mature, established in 
1975 
 Focused on knowledge 
creation and capacity 
building 
 Strategy in place 
 KPIs in place 
 Large budget 
 Large amount of staff 
 
D. Constraints and limitations 
Although the Review shares many similarities to an Evaluation, this formal Review project 
is not an Evaluation and as such does not explicitly follow standard Treasury Board criteria 
for evaluation studies.  
The availability of performance data was limited at the time of the Review.  An Evaluation 
Strategy was recently adopted by the GHRI (2009/10) and the first indicators report 
prepared in July 2010.  This first indicators report addresses the first of objective in the 
GHRI strategy (1 of 3) and summarizes data from six GHRI projects. 
The scope of this Review did not permit for additional collection of performance data.  No 
primary research was undertaken to assess progress made and/or impacts achieved by or 
through GHRI.  Our assessment of these two variables, i.e., progress and impacts, was 
mainly based on available and recent documentation supported by the input of stakeholders 
interviewed.  
Key informants were selected by the GHRI Secretariat and Steering Committee members.  
The respondent pool was somewhat limited, in some cases not large enough to characterize 
a representative sample (i.e., researchers, other government departments).  Due to small 
sample sizes, for the most part, the report has aggregated results of interviews across all 
key informant groups. 
Original examples of outputs or outcomes identified through the interview program of 
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II. GHRI Relevance and Need  
The review questions addressed in this section of the report include: 
 
Question #1: “Is the GHRI relevant and what merits does the partnership 
arrangement possess?”   "Is the GHRI relevant?” is addressed in this section of the report 
whereas   “…what merits does the partnership arrangement possess?” is addressed in 
Chapter IV of this report. 
Question #2: “Is there an on-going need for GHRI?” 
 
Key findings: 
 GHRI is seen as relevant and a key contributor to Canada’s commitment to addressing 
global health issues.  It is aligned to the mandates of the partner departments/agencies. 
However, there is opportunity for enhanced clarity and alignment between the GHRI 
mandate and priorities and the priorities of each partner department/agency. 
 There are no known other programs within Canada or internationally that provide the 
same opportunities for researchers to build the global health research area across many 
different facets (knowledge creation, capacity building, and knowledge translation).   
 Many interviewed key informants indicated that if GHRI is to remain relevant, needed, 
and supported, there is a requirement for change.  
 Within the context of the current projects, GHRI has provided options for global health 
research that would likely not have been possible. 
 GHRI is a unique model in its partnerships between Canadian researchers, LMIC 
researchers and research users and is seen as a critical enabler in the establishment of 
global health research programs. 
 In order to sustain its current achievements, opportunities exist to better define 
priorities and related expected outcomes among partners and increase visibility and 
connection to internal and external stakeholders. 
A. Initial Relevance and Need  
Through review of available and relevant background documentation and discussions with 
identified and targeted key informants, we understand that the Government of Canada’s 
Global Health Research Initiative was established in November, 2001 under the terms of a 
Memorandum of Understanding (MOU) between: 
 International Development Research Centre (IDRC) 
 Canadian Institutes of Health Research (CIHR) 
 Health Canada (HC) 
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In October 2008, a decision was made to add the Public Health Agency of Canada (PHAC) 
to the GHRI partnership thus resulting in an amended MOU. 
As stated in the Global Health Research Initiative, Update 2009-2010, the partnership was 
designed to bring the collective knowledge, leadership, and mobilization capabilities of its 
partners to bear on global health priorities. To this end, a number of factors motivated the 
individuals responsible for establishing GHRI to create a research partnership focusing on 
global health issues.  These included: 
 A growing realization that the threat of pandemic influenza as well as new and 
emerging infectious diseases would require unprecedented global cooperation to 
prepare effective responses. 
 A greater understanding of the potential impacts of global warming and climate change 
on the risk of transmission of diseases (such as dengue fever) in areas of the world 
previously unaffected, possibly including Canada. 
 Increasing concern over the impact of HIV/AIDS around the world, particularly in sub-
Saharan Africa. 
 A need for compelling, timely evidence from high quality research to mobilise action 
on health-related Millennium Development Goals (MDGs). 
 A desire to find scientific solutions to long standing global health problems such as 
malaria and tuberculosis. 
 A recognition of the need to make research results more accessible for practical use by 
wide audiences, especially results that add to our understanding of the factors that 
make up good health, improve the organization and delivery of care, and strengthen 
health systems.3 
In addition, the MOU recognized there were distinct advantages and benefits from a 
Canadian context in that “investing in these global public goods could have the double 
advantage of improving the effectiveness and cost-effectiveness of official development 
assistance (ODA; improved sustainable health gains per dollar of Canadian ODA 
invested) and contribute to the protection of the health of citizens of all countries, including 
Canadians. Diseases know no borders. Health events and issues in other countries 
increasingly impact on the health of Canadians and the Canadian health system.” 
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As stated in the 2001 MOU and 2008 amendment, together the partnering agencies, funded 
by the Government of Canada, can bring expertise to bear on health problems in 
developing countries and global health priorities: 
 Health Canada, with its considerable knowledge base and recognized leadership. 
 IRDC, with its experience with research in developing country settings. 
 CIHR, with its strong tradition of excellence in research through the peer-review 
process. 
 CIDA, with its considerable development experience and its emphasis on evidence 
based health development. 
 PHAC with its role in helping build an effective public health system in Canada and 
responsibility for surveillance, monitoring, researching, investigating and reporting on 
diseases, injuries, other preventable health risks and their determinants, and the general 
state of public health in Canada and internationally.4 
The mission of GHRI is to fund research on global health problems, strengthen capacity to 
perform research and to use research findings to deal with global challenges. In doing so, 
the Initiative promotes and facilitates inter-disciplinary research to address global health 
challenges.  Six distinct areas of research are currently supported through GHRI, namely: 
1. Eco EID:  Ecohealth Emerging Infectious Diseases Research Initiative ($4.9-million in 
GHRI funding) 
2. HIV-AIDS Prevention Trials Capacity Building Grants (Phase II $6.7-million and 
Phase IIb $10-million)5 
3. Canadian International Immunization Initiative (Phase II $2.7-million) 
4. Haiti Immunization Program ($1.055-million) 
5. African Research Partnership  Program ($5.9-million) 
6. Teasdale-Corti Research Partnership Program ($24.6-million). 
 
B. Current Alignment of GHRI to Partner Mandates and 
Priorities 
There is alignment of the GHRI funded research with the strategic outcomes of its partner 
departments and agencies as well as the whole of Government Performance Framework.  
The following exhibit aligns the partner departments and agency strategic outcomes against 
the whole of government framework and identifies how GHRI may be seen within the 
overall health agenda. 
                                                     
4 Global Health Research Initiative, Memorandum of Understanding in Support of Better Health for the Poor – 
A Canadian Collaboration for Global Health 




 18  
Exhibit 2 
Alignment of GHRI to Partner strategic outcomes6 
Org Strategic Outcome/Mission
GOC Whole-of-government Framework (relevant to Global Health Research)
Economic Affairs Social Affairs International Affairs
An innovative and knowledge-
based economy Healthy Canadians A safe and secure Canada
Global poverty reduction through 
sustainable development
(fund and support academic research 
and research partnerships in health)
(support applied health research for 
policy development)
(build preparedness for and 
responses to health-related 
emergencies)
(conduct research aimed at 
improving the quality of life in 
developing countries)
CIDA Reduction in poverty for those 
living in countries where CIDA 
engages in international 
development
• Fragile Countries and Crisis-
   Affected Communities
• Low-Income Countries
• Middle-Income Countries
• Global Engagement and
   Strategic Policy
• Canadian Engagement
CIHR A world-class health research 
enterprise that creates, 
disseminates and applies new 





• Health and Health
  Services Advances*
IDRC To promote research in developing 
countries, research by people of 
those countries, for the purpose of 
applying knowledge
• Complementing Thematic
   Programs • Health and Health Systems
HC Accessible and sustainable health 
system responsive to the health 
needs of Canadians
• Canadian Health System
• Canadian Assisted Human
   Reproduction
• International Health Affairs*
PHAC Canada is able to promote health, 
reduce health inequalities, and 
prevent and mitigate disease and 
injury
• S&T for Public Health
• Surveillance and Population
   Health Assessment
• Public Health Preparedness
   and Capacity*
• Health Promotion
• Disease and Injury 
   Prevention and Mitigation
• Regulatory Enforcement
  and  Emergency response
• Health Policy and Health
   Systems
• Prevention and Control of
   Pandemics and Emerging
   Infectious Diseases
• Prevention and Control of
   Chronic Diseases
• The Interaction of Health,
   Environment, & Development
Priority Research Themes




GHRI Fund research on global health 
problems, strengthening the 
capacity to do research and to use 




                                                     
6 Data presented in this exhibit have been taken from Departmental Reports on Plans and Priorities (RPPs) 
2010/11 except for IDRC where information was obtained from its Strategic Framework 2010-2015 and the 
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C. Perceived Current & On-going Relevance and Need 
Through the conduct of focused interviews with a cross-section of key informants, as 
outlined in the Review scope and approach section of this report, the following key themes 
emerged concerning the perceived current and on-going relevance and need for GHRI. 
 The majority of interviewed key informants support the concept of a ‘whole of 
government’ approach to global health research and believe that Canada has and can 
continue to be a recognized leader internationally.  
Further, there is a perception that Canada can make a 
meaningful contribution to the advancement of global 
health research and, in effect, global health and global 
health systems. 
 GHRI is unique in its form.  There is no other program 
nationally or internationally that provides the same 
opportunity for research (knowledge generation) and 
capacity building at the same time in addition to the distinctive requirement of 
Canadian-LMIC co-leadership as well as the involvement of users.    
 This said, many interviewed key informants indicated that if GHRI is to remain 
relevant, needed, and supported, there is a requirement for change. The most frequently 
reported suggested changes included: 
 Clear alignment between the mandate, priorities and initiatives of GHRI and the 
priorities of the “Government of the day”.  Leveraging new/renewed priorities as 
opportunities present themselves (e.g., 2010 G8 summit commitment by Canada to 
provide $1.1 billion to the Muskoka Initiative—money for health and nutrition 
programs that benefit women and children in developing countries) will help to 
solidify the establishment of GHRI as an instrument to advance the Government of 
Canada’s and partner agency’s priorities.  
 A common set of clearly defined GHRI priorities that can be supported by all 
GHRI partner agencies. 
 Clear definition of the outcomes to be achieved through GHRI and how these 
outcomes will produce value and measurable results/impacts for each partner 
agency (in return for the contribution/investment made) and the advancement of 
the Government of Canada’s priorities, e.g., Maternal and Child Health. 
 Increased engagement/involvement in GHRI among Heads of Agency to elevate 
the relevance, need and value of GHRI within each partner agency and across 
Government. 
 Increased collaboration with complementary organizations/initiatives, e.g., the 
Development Innovation Fund delivered through Grand Challenges Canada, 
Canadian Academy of Health Sciences, and the Canadian Society for International 
Health, etc. 
 There is a perception among some interviewed key informants that if GHRI is to 
continue to be of relevance, it must be both a strategic catalyst and an implementer of 
global health research programs. There is a belief among many interviewed key 
informants that GHRI in its current state is not performing as an effective strategic 
catalyst for exploring, influencing or defining Canada’s role and/or contribution to 
global health research but has the potential to.  
“Through the lens of 
Canadian/South 
research collaborations, 
GHRI is a big player.”   
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Some of the key results reported in the GHRI: Outcomes from 2002-2003 Developmental 
Programs Report completed in 2010, support the continued relevance and need of the 
GHRI with the following conclusions: 
 The grants were highly valued by both newer and more experienced global health 
researchers. 
 Of the 13 grant PIs interviewed, almost all believe their global health research projects 
would not have been undertaken without the developmental GHRI funding. 
 For 4 PIs, the GHRI funded project was an important base for a subsequent long-term 
research program, and 7 more PIs report that their whole subsequent research program 
would not have happened without the GHRI funding. 
 Teams found the grants particularly critical in providing time and funds to develop 
substantial partnerships; these GHRI-supported relationships are at the heart of most of 
their on-going work. 
The results from the current interviews with researchers are consistent with these earlier 
findings.   
 All researchers, both from Canada and LMICs, indicated that their project would not 
have taken place without GHRI funding. 
 All researchers interviewed to date, both from Canada 
and LMICs, indicated it was not very likely or not at all 
likely their research would have been funded by some 
other organization, whether within their home country 
or internationally.  The unique approach and 
perspective of GHRI on research and capacity building 
is difficult to fit into the typical research paradigm in 
Canada and for LMICs, the funding is really not there at all.  This is supported by 
external key informants as well.  A majority of external respondents could not 
identify another program within Canada providing the same type/level of support for 
global health research. 
“There are a huge number of researchers and global health 
research questions but virtually no programs to carry out the 
interest . . . GHRI is very important.” 
External GHRI Stakeholder 
The post-report from the 2009 Teasdale-Corti Team Meeting involving Canadian and 
LMIC researchers and representatives of the GHRI secretariat also identified ongoing need.  
“A balance between research, capacity building and knowledge translation and extension 
was advocated.  Investment in capacity building, including research infrastructure, 
institutional processes, and networking of research and research users remain important 
gaps that need continued attention.” 
“Currently, GHRI is   
absolutely critical.”   
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III. GHRI Progress and Impacts 
The review question addressed in this section of the report included:   
 
Question #4: “What impact has the Initiative achieved?” 
Key findings: 
 Impacts are being achieved in GHRI’s strategic direction areas:  Knowledge Creation, 
Capacity Building, and Knowledge Translation with results being achieved or highly 
anticipated across many different areas.  
 Research capacity in Canada and low- and middle-income countries has increased.  
Increased opportunities, credibility of programs, and growth in relationships, networks 
and collaborations have contributed to growing or expansion of research programs. 
 However, ad hoc funding may be limiting the reach of GHRI programs.  GHRI 
operating in “reaction” to availability of funds and funds attached to specific 
departmental mandates may be restricting.  Respondents felt impacts may be greater if 
more flexibility was built into the funding model.  
 Increased levels of “knowledge brokering” of research results to partners and other 
stakeholders (and potential stakeholders) would improve progress and potential for 
additional impacts. 
 
A. Summation of Recent and Available Performance 
Results 
In preparation of the methods used to address the review questions relating to progress and 
impacts (keeping in mind the limitations around performance data documented earlier), it 
was determined numerous efforts to document results had already been completed or were 
in process of being finalized by the GHRI that would be highly complementary to this 
Review.  Numerous studies have been commissioned to investigate and document results 
of GHRI activities.  Namely three key reports have been commissioned documenting the 
results and impacts of the GHRI and its research projects: 
 Global Health Research Initiative (GHRI):  2009 Progress Report, March 2009. 
 Assessing Global Health Research:  The Application of Bibliometrics, March 2010. 
 Global Health Research Initiative (GHRI):  Outcomes from 2002-2003 Developmental 
Programs, June 10, 2010. 
The GHRI 2009 Progress Report documents program achievements in the following areas 
contributing to the GHRI strategic directions of knowledge creation, research capacity 
building and knowledge translation: 
 Increased LMIC leadership and control inherently through eligibility requirements for 
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GHRI programs as well.  This is also leading to increased potential for leverage, 
reputation, resources and buy-in of the projects (for both LMICs and Canada). 
 Increased decision-maker leadership also inherently (in some cases) through eligibility 
requirements for GHRI funding support, leading to more possible relevance to LMICs 
and pragmatic approaches to working in the existing environment (i.e., existing skills, 
existing resources, political situations, etc.).  This is also leading to increased research 
implementation and ownership of the results by the LMIC leaders. 
 More knowledge exchange among LMICs increasing LMIC-to-LMIC linkages for the 
transfer of research expertise, exchange of ideas and knowledge. 
 Better support (from GHRI staff) to research teams contributing to increased capacity 
building and the establishment of networks. 
 Higher status for global health research. 
 Building sustainable global health research relationships and outcomes.  Reportedly, 
implementation of LMIC-lead research results have greater opportunities for 
continuation as (noted above) projects are built on the existing environments. 
The report also identified opportunities available to GHRI to make larger impacts in 
moving its strategic direction forward which mainly centre around increasing emphasis on 
knowledge translation and the assimilation and sharing of results from the project level, to 
the program level, across projects and programs, and beyond.   
Documented in the report “Outcomes from 2002-2003 Developmental Programs” are the 
following key messages: 
 The creation of GHRI has influenced the visibility and attention paid to global health 
research and ultimately its credibility among the health research community. 
 85% of respondent researchers were able to maintain a primary focus on global health 
research projects following funding from GHRI. 
 Researcher productivity of GHRI funded PIs increased approximately five-fold 
following their grants; however, no publications could be traced for about one-third of 
the grants.  (See next section on bibliometric study). 
 Initial projects from 2002/03 are influencing program and policy decisions through the 
LMIC partners resulting in a wide range of health system changes. 
In addition, the GHRI has looked at success and achievements internally and, for example, 
has documented such in the post-report of the 2009 Teasdale-Corti Team Meeting held in 
Cairo, Egypt, October 2009.  The input provided by the Teasdale-Corti teams identified 
impacts.  The following impacts were selected from the summary of the group sessions 
held on Day 1 of the meeting:   
 Infrastructure, relationships and personnel for research are or are being established. 
 Research questions are gaining profile and support in host countries. 
 Linkages between researchers and research users are being established. 
 Linkages to policy makers and decision makers have started. 
 A spectrum of people, from community members to government officials have been 
attracted, allowed, trained and supported to participate in team research. 
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 Unique trainee experiences are underway.7 
The bibliometric study, Assessing Global Health Research: The Application of 
Bibliometrics, Mark Bisby, March 2010, concluded that interest and involvement of 
Canadian researchers in global health have increased significantly over the past 10 years 
yet was not able to demonstrate sizeable findings in relation to research publication 
productivity for GHRI funded projects.  The study concluded that there was low 
publication productivity for the GHRI funded projects (time period covered was 1997 
through 2009) and that the GHRI had yet little influence on recent Canadian publication in 
support of research conducted by Canadian and LMIC researchers.  
However, it is important to interpret the results of the bibliometric study in context.  The 
report provides specific caveats that it is still “early days” for most GHRI projects as well 
as identifying that the publication of research results has not been a major objective of the 
GHRI funding programs alone.  The fact that by and large publication only occurs several 
years after a funding program has ended was also acknowledged.  So in fact, looking at the 
time period covered by the bibliometric review (1997 through 2009), Exhibit 3 establishes 
three programs in place that may have been expected to have publications discovered 
during the bibliometric review namely:  CIII2, CHVI Phase I, and perhaps some of the 
Teasdale-Corti team grants.   
 
Exhibit 3 






Teasdale-Corti Research Partnership 
Program (Teasdale-Corti) 
2006-2010 4 years 
Canadian International Immunization 
Initiative (CIII2) 
2003 – 2009 7 years 
Haiti Immunization Program (CIII2-Haiti) 2008—2013 2 years 
HIV-AIDS Prevention Trials Capacity 
Building Grants (CHVI Phase 1) 
2006—2008 3 years 
HIV-AIDS Prevention Trials Capacity 
Building Grants (CHVI Phase 2) 
2009 – 2014 1 year 
African Research Partnership  Program 
(AHSI-RES) 
2008 – 2013 2 years 
Ecohealth Emerging Infectious Diseases 
Research Initiative  (ECOEID) 
2009 – 2015 1 year 
*These dates are program dates and may not reflect actual funding periods.  Projects may have 
started later. 
                                                     
7 Post-meeting report, Global Health Research Initiative, 2009 Teasdale-Corti Team Meeting, Cairo, Egypt, 
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The GHRI should continue to recognize the importance as well as the limitations of 
bibliometric review, being one component of its overall evaluation strategy.  As outlined in 
the current 2010 bibliometric study the appropriate weighting of bibliometric results within 
the overall framework of indicators will be a valuable contribution to GHRI’s definition of 
“success” 
Since the time of the bibliometric review in early 2010, GHRI has embarked upon the 
implementation of an evaluation strategy and the first indicators report8 was drafted using 
six of the Teasdale-Corti Team Grant projects.  These six projects have been documented 
to have produced 8 peer-reviewed articles/publications signifying that publication is indeed 
starting to take place. 
Other results of interest taken from the first GHRI indicators report (based on 6 Teasdale-
Corti projects) are as follows: 
Indicator Result9 
 Collaboration between researchers and research-users in 
projects funded by GHRI • 61 
 # of Canadian institutions networked in GHRI projects: • 28 
 # of LMICs institutions networked in GHRI projects: • 133 
 # of projects funded by GHRI: • 5410 
 # of people on proposals submitted for funding by GHRI: • Average 7.8 
 Knowledge transfer activity by projects funded by GHRI: • Web site 
development 
5of 6 projects 
 Publication counts • 11 outputs11 
 LMIC individuals as first authors • 2 of 11 (18%) 
 Co-author analysis • International: 9 
• National: 7 
• Industry: 0 
• Other disciplines: 7 
 Field analysis of citations (citations outside global health) • 1 
 Proportion of projects’ funds allocated by GHRI that are 
directly managed by a LMIC grantee • 39% 
 Capacity building of individuals by projects funded by 
GHRI (# of individuals) • 2,154 
 Capacity building of networks by projects funded by GHRI 
(# of networks) • 10 
                                                     
8 Global Health Research Initiative (GHRI) – Evaluation, Indicators to measure GHRI achievements, Indicators 
Report #1 – Preliminary, July 26, 2010. 
9 Indicators include results from 6 projects of the Teasdale Corti Team Grant program. 
10 2006-2009, 6 calls (54 projects) 
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 Capacity building of organizations (# of organizations) • 128 
 Graduate students funded • 47 
 Graduate students’ completion rate • 17%12 
 Funding of graduate education by projects • >$600K 
 Graduated research students in health-related subjects • 9 of 47 
 Consultations to policy makers • 10 
 Consultations to advocacy groups by projects funded by 
GHRI • 4 
 Number of presentations given by projects funded by GHRI • 142 
Indicator Result13 
 Number of non-health related policy makers provided with 
consultation by projects funded by GHRI • 8
14 
 Number of presentations given outside health by projects 
funded by GHRI • 9
15 
 Consulting to advocacy groups outside health by projects 
funded by GHRI • 3
16 
 Researcher reported use of findings outside health • 0 
 Media citation analysis:  newspapers • 24 
 Collaborations of projects funded by GHRI with other 
components of the innovation system • 2 
 Grants funding allocated by GHRI partner agencies and 
departments • $31.9M
17 
 Funding leveraged from external sources by GHRI • 0 
 Funding allocated to GHRI funded projects by LMICs • $89K 
 
As the Evaluation Strategy, Evaluation Plan and Performance Monitoring Plans are put in 
place and begin to mature, GHIR intends to reassess and interpret the results with enhanced 
qualitative descriptions of achievements in areas such as advancing science, informing 
decision-making, and transformative effects. 
For a complete information on methods, and details of indicators (including examples), the 
reader is referred to the original report prepared by GHRI. 
 
                                                     
12 Completion rate for graduate students funded by GHRI to date 
13 Indicators include results from 6 projects of the Teasdale Corti Team Grant program. 
14 By one project 
15 By two projects 
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B. Perceptions from key informants 
Based on the interviews conducted to date with Canadian and LMIC researchers, results 
are consistent with the document review and the results of the performance studies 
undertaken by GHRI.   
 The GHRI is providing Canadian and LMIC researchers with an option for their 
research programs that would not likely have been possible had GHRI not been in 
existence.   
 Canadian and LMIC researchers noted increased credibility of their research programs 
allowing them to continue and/or expand their research programs. 
 One of the most cited impacts is the influence GHRI has had on researcher’s 
establishment of relationships, networks, and other research collaborations. 
In relation to the generation of impacts, researchers were asked to comment on the impacts 
their research projects have had, or are anticipated to have in the future, associated with the 
three strategic directions set by the GHRI: 
 Knowledge Creation:  strengthening global health research in Canada and in low and 
middle-income countries;  
 Capacity Building:  Building research capacity to deal with global health challenges; 
and 
 Knowledge Translation:  Strengthening the capacity to use global health research 
results. 
Both Canadian and LMIC researchers interviewed were able to discuss impacts being 
achieved or anticipated in all three areas.  Generic examples** are provided below: 
Knowledge Creation Capacity Building Knowledge Translation 
 Development of 
empirical and scientific 
data to support evidence 
based decisions.  
 South/South sharing of 
information and/or 
experience for similar 
problems and the 
determination of possible 
solutions.  
 Much needed research 
being undertaken in 
relation to long standing 
problems. 
 
 Creation of new 
university programs in 
LMICs. 
 Multi-disciplinary 
training occurring across 
LMIC Ministries. 
 Increased networking has 
encouraged further 
collaborations building 
expertise and credibility 
of researchers. 
 
 Training of students. 
 Increased capacity for 
 Continuing work that 
will bring LMIC 
partners to Canada as 
experts to look at 
changing practice and 
policy domestically in 
Canada.   
 South /south 
collaborations have 
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 Increased awareness of 
public health issues in 
LMICs. 
collaborations and 
discussion among LMIC 
Ministries and local 
stakeholders. 
 
influencing the uptake 
of Canadian standards 
in LMICs. 
 Sharing results with 
other international 
funding agencies where 
these agencies are 
approaching the LMIC 
for information.   
 Sustainable training 
models – i.e., “train the 
trainer”. 
 
**Due to issues of confidentiality surrounding the researcher respondent group, detailed 
examples are not provided.  Should the reader wish to obtain specific details on impacts 
being made in each of the three strategic areas, we would refer to the GHRI 2009 Progress 
Report prepared by Michelle Campbell, March 2010 as the achievements of some 70 
projects are fully documented in this report. 
There were no formal definitions of Knowledge Creation, Capacity Building, or Knowledge 
Translation provided to the researchers before or during the interviews.  The resulting 
responses are based on the interpretation of the meaning of these terms by the researchers 
themselves. 
Through the conduct of focused interviews with a cross-section of internal and external 
respondents (not including researchers), as outlined in the Review scope and approach 
section of this report, the following key themes emerged concerning the perceived progress 
and/or impact GHRI has had. 
 When asked about the progress made and impacts achieved, the Teasdale-Corti 
Research Partnership Program was the most commonly cited example of a positive 
impact made by and through GHRI.  Some individuals suggested that as long GHRI 
exists, an impact will be made; however, the degree of impact is and will continue to 
be limited given the levels of funding available.  
 Some interviewed parties suggested that GHRI operates on an opportunistic basis as a 
result of the current ad hoc funding model and that this has and will continue to limit 
the impacts that can be made.  Funding tied to specific partner mandates can be a 
restriction.  It was suggested that more flexibility be considered, perhaps a separate 
funding authority (or program budget) be established.  
 It was noted by many interviewed parties that more needs to be achieved in the area of 




 28  
 It was suggested that more progress could be made and impacts achieved through the 
GHRI Secretariat increasing its efforts to be the ‘knowledge broker’ among the five 
partner agencies as well as other organizations/initiatives with complementary 
mandates and priorities. 
 A few interviewed key informants indicated that GHRI has contributed to their 
agency’s / department’s approaches and strategies; however, the majority of those 
interviewed were unable to draw this same conclusion. 
 Many interviewed key informants indicated that they believe GHRI has the potential to 
generate meaningful impacts but that this will only be possible through a strengthened 
partnership, clear alignment between the mandate, priorities and initiatives of GHRI 
and the priorities of the “Government of the day”, a common set of clearly defined 
GHRI priorities that can be supported by all GHRI partner agencies, and establishment 
of GHRI as an instrument to advance the Government of Canada’s and partner 
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IV. The Partnership   
The review questions addressed in this section of the report include: 
 
Question #1:  “…what merits does the partnership arrangement possess?”   
The first part of this question, i.e., “Is the GHRI relevant?” was addressed in Chapter II. 
Question #5: “Does the partnership provide value-added that would not be possible if 
the partners acted independently in this area?” 
Question #6: “How has the overarching MOU and partnership composition worked?” 
Key findings: 
 GHRI is seen as a valuable mechanism to deliver global health research programs. 
 Pooled funding and the integrated partner approach have resulted in a stronger 
investment in global health research that may not have otherwise been possible. 
 GHRI’s integrated partner approach has helped enhance Canada’s image on matters 
pertaining to global health and global health research. 
 More effort is required to develop key strategic external relationships with other 
synergistic organizations. 
 Clarity of roles, responsibilities, value propositions, common priorities and individual 
expected returns is a key foundational element that Partners are missing.  
 Increased visibility for GHRI at senior levels (including Heads of Agency) is 
warranted.  Full engagement of “champions” in meaningful ways is required to drive 
consensus around strategy and priorities for the Initiative.   
 The membership of the GHRI Steering Committee is not seen to be consistent with the 
senior levels required to meet the accountabilities of such a group.  Operational 
activities undertaken by this group are taking away from the critical strategic role 
necessary to move forward. 
 Some administrative struggles exist in the areas of funding and financial arrangements. 
 
A. Memorandum of Understanding (MOU) Overview  
A Memorandum of Understanding was initially signed by four federal government 
departments in November 2001.  The newly formed partnership included the Canadian 
Institutes for Health Research, the Canadian International Development Agency, Health 
Canada, and the International Development Research Centre.  The MOU was amended in 
2008 to include the Public Health Agency of Canada as a signatory. 
The MOU commits each of the partners to collaborate in international health research 
projects and programs addressing global health issues.  The work to be undertaken through 
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research area by leveraging the unique strengths and expertise of all partners.  The MOU 
specified: 
“These mechanisms will include at least the following:  
 Parallel funding of different components for joint research programs; 
 Joint review of project and programs through participation in relevant approval 
committees; and 
 Co-funding of international heath research projects and programs.”18 
Although these three mechanisms were specifically identified, the MOU did not limit the 
partners to employ only these means.   
The Global Health Research Initiative was established under the terms of the MOU to 
facilitate delivery on the commitment of the now five partners. 
GHRI responds to the commitments made in the MOU by centring on three key strategic 
areas: 
1. Knowledge Creation:  Strengthening global health research in Canada and in low and 
middle-income countries. 
2. Capacity Building:  Building research capacity to deal with global health challenges. 
3. Knowledge Translation:  Strengthening the capacity to use global health research 
results. 
In turn, these three key strategic areas are applied against GHRI’s current priority research 
themes which are: 
 Health policy and health systems 
 Prevention and control of chronic diseases 
 Prevention and control of pandemics and emerging infectious diseases 
 Interaction of health, environment, and development. 
 
B. Collaborative Relationships 
The key theme emerging from the interviews with a cross-section of key informants is the 
increased importance of GHRI maintaining and developing appropriate constructive 
relationships.  Internal and external interviewees noted some effort being placed in the 
development of strategic linkages and relationships but most felt that this was an area that 
could be improved upon.  Linkages to other external partners or potential partners were 
noted to be a little ad hoc at this point in time.  Internal and external interviewees suggested 
that more time be spent thinking about other relationships, whether it be with other 
government departments (i.e., Industry Canada, DFAIT, CFI, the granting councils, etc.), 
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NGOs, other Canadian initiatives like Grand Challenges or other global organizations and 
programs. 
GHRI has already identified this as one of its potential future areas of attention as well19.  
“Linkages with existing centres of innovation; ongoing networks and research consortia” 
will be important to GHRI’s future sustainability. 
 
C. Governance 
The governance structure of the GHRI partnership is comprised of three elements: 
 Heads of Agency – most senior leaders of each GHRI partner (i.e., Presidents and 
Deputy Ministers). 
 Steering Committee – members of the Steering Committee are appointed by their 
home department/agency.  There are typically two representatives selected from each 
GHRI partner. 
 Secretariat – operational staff that act to implement GHRI projects and programs and 
serve to support the Steering Committee. 
Numerous changes have occurred over the 10 year time frame.  These have been 
purposeful changes such as the Secretariat staffing up to a level that enables it to respond to 
its mandate as the Initiative has grown (based on recommendations made during the last 
review in 2006), and evolution of the Steering Committee to reflect increasing maturation 
of the GHRI (i.e., formal terms of reference in place). Inevitably, there has also been 
turnover in department/agency representation on both the Heads of Agency Committee and 
the Steering Committee.  The following key themes emerged from key informant 
interviews in relation to governance mechanisms in place for the GHRI: 
Heads of Agency: 
 Increased engagement/involvement among Heads of Agency in a meaningful way is 
required to empower the drive for consensus around strategy and priorities for the 
Initiative.  It was noted that momentum in this regard has somewhat diminished 
compared to what was initially transpiring.  This was attributed to possible lack of 
information reaching this level of senior management within the partner 
agencies/departments, and the current economic and political climates.  The required 
increased engagement of Heads of Agency was mentioned by both internal and 
external respondents.  It was noted to be necessary by both respondent groups to really 
engage the Heads as “champions” to increase the profile of the initiative as well as 
leverage their respective positions to best benefit the work undertaken through GHRI 
(e.g., Grand Challenges has two GHRI partner departments on its Board of Directors).  
Internal respondents noted more substantive discussions at this level could be 
occurring so as to in turn help the Heads see the value position of shared ownership, 
iterate the interest across research disciplines in the subject areas of global health 
research, remain engaged and position GHRI within the government’s accountability 
framework.  
                                                     
19 GHRI Planning Day April 13, 2010, Pre-reading material, Concepts & Options for Renewal with special 
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Steering Committee: 
 The functioning of the Steering Committee has improved over the last year or so.  
Increased organization and streamlining of processes as well as more substantive 
discussions are taking place.  That said, it was suggested by many interviewed key 
informants that there should be less focus on administration and more focus on 
strategic decision-making and oversight. Further, it was suggested that the Steering 
Committee should turn some attention to global health policy, the Government of 
Canada’s global health research priorities, determining if gaps exist that, if not bridged, 
will impact Canada’s ability to realize its defined priorities, identifying possible 
bridging options, assigning responsibilities, monitoring and tracking process against 
priorities and disseminating information and knowledge.  
There is a need for a “true-champion” at the senior level, e.g., ADM or senior DG, 
representing each partner organization with easy access to the Head of Agency.  There is a 
perception that the current Steering Committee composition has a mix of senior and mid-
level management at the table.  Uncertainties were raised as to fit between some Steering 
Committee members and the requirement that they be challenged with stimulating and 
influencing the recognition and buy-in of GHRI within their home organizations.   
 There is a potential for the involvement of other stakeholders to be invited as 
participants in the Steering Committee to assist in defining priority areas and 
contributing to research opportunities (e.g., Environment Canada and Agriculture and 
Agri-Food Canada).  
 Connections by the Steering Committee members back to their home organizations 
requires further development and effort by all parties.  “Hooks” into synergistic 
programs within partner departments would be beneficial.  
GHRI Secretariat: 
 There is a perception among some interviewed key informants that there is a 
need/opportunity to clarify and possibly expand the go-forward role and 
responsibilities of the GHRI Secretariat. It has been suggested that responsibilities 
could perhaps be expanded beyond that of administrative coordination and 
implementation to include being a strategic catalyst and a coordinator and broker of 
knowledge across the GHRI partnership and possibly with other complementary 
initiatives funded by the Government of Canada.  This may require a revisit of the 
GHRI Secretariat staff skill mix so as to ensure it, at a minimum, has planning, strategy 
development and facilitation skills resident within. 
 Also raised were issues around the Secretariat’s role in relation to the department that 
houses it and the other partners.  Examples of some of the issues raised are 
accountabilities and first line reporting to host agency can sometimes raise perception 
of perhaps not respecting the “partnership” at times and how much autonomy GHRI 
staff has in balance with requirements of host agency particularly when dealing with 
administrative issues.  These concerns were raised by internal respondents. 
 The initiative appears to still be struggling with varying administrative requirements of 
partner departments, most notably funding and financial arrangement/reporting (i.e., 
different conditions placed on the administration and conduct of research programs by 
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D. Perceived Value 
Through the conduct of focused interviews with a cross-section of key informants, as 
outlined in the Review scope and approach section of this report, the following key themes 
emerged concerning the perceived value of GHRI. 
Value contribution as demonstrated by: 
 There is a perception among some interviewed key informants that GHRI has made a 
valuable contribution since its inception to global health research approaches and 
strategies.  Historically, each of the partners had invested little in this area.  
 On the matter of funding available, it was suggested by one interviewed stakeholder 
that the Government of Canada’s contribution to and impact on global health research 
is stronger as a result of the partner agencies pooling the limited funding they have and 
that if the partnership did not exist, the impact on global health research would be 
much less significant.   
 GHRI helps enable a forum for a coordinated and collaborative ‘whole of government’ 
approach to global health research. This has helped position and perhaps enhanced the 
image of the Government of Canada in matters pertaining to global health and global 
health research. 
 GHRI provides Heads of Agency with an opportunity to engage in dialogue concerning 
global health research albeit once a year. 
 There is a belief among some interviewed key informants that the coordination and 
leveraging of additional funding on the part of partner agencies has contributed to the 
initiation of more meaningful and valuable research projects that would not have 
otherwise been possible.  
 It is recognized by some interviewed key informants that every partner brings 
something different to GHRI and that if there was no integrated partnership, the nature 
of what GHRI does/enables would not be possible.  Teasdale-Corti Research 
Partnership Program is one example of this cited by many. 
 GHRI is seen by researchers as a “Canadian” initiative and this carries weight with 
LMICs and people like it.   
One distinctive value proposition of the GHRI partnership was also cited by the 
Directors General Working Group on International Science and Technology in their 
report “The Government of Canada’s engagement in international Science & 
Technology and the path forward20: 
“Examples of interdepartmental collaboration such as the Global Health Research 
Initiative demonstrate that there are new interdepartmental models of international 
S&T collaboration that leverage the capabilities of expertise within government and 
academia and contribute to improved coordination and leveraging of resources.   
 While examples such as GHRI are important, they are the exception to the rule and 
opportunities for increased collaboration and synergies through new multi-
institutional program initiatives should be encouraged . . . ” 
                                                     
20 Unpublished:  The Government of Canada’s engagement in international Science & Technology and the path 
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Conversely, some of the value contributions were contrasted by: 
 To some, the role of all partners is not clear and it was noted that some 
departments/agencies stand out more than others.  Those partners that provide a 
majority of funding were thought to be recognized more.   
 There is a general belief among many interviewed key informants that there is a need 
for all partners to understand what each other’s unique yet complementary contribution 
to GHRI is and will be going forward. There is a general feeling today among some 
interviewed key informants there are two types of partners, i.e., funding and non-
funding.  It was suggested by some interviewees that this view must change if the 
partnership is to continue and to be a success. 
 There is a belief among many interviewed key informants that there is a lack of 
recognition for the value GHRI does and can bring to the Government of Canada’s 
priorities. This may in part be due to the absence of clearly aligned GHRI, partner 
agency and Government of Canada priorities and limited engagement on the part of 
Heads of Agency. Some believe that GHRI needs a political champion. 
 There is a belief among some interviewed key informants that while complementary 
relationships exists between and among the five partner agencies, the full potential of 
benefits has not been derived to date. Perhaps as a result of a combination of factors 
including: the current governance model; the absence of a set of common priorities 
clearly aligned with the priorities of each partner agency and with the priorities of the 
Government of Canada; limited Heads of Agency engagement and evident 
commitment; the constraint of ad hoc and limited funding for research projects; 
absence of a Government of Canada global health research strategy; and a perceived 
absence of strategic action on the part of the Secretariat  (i.e., regular environmental 
scanning – what’s going on in the global health research landscape, identification of 
threats/opportunities) 
 Some key informants noted a “tenderness” exists due to unequal research funding 
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V. GHRI As A Model 
The review questions addressed in this section of the report include: 
 
Question #7: “Is GHRI the right model?”  
Question #8: “Are there comparable models that may provide lessons or insight into 
possible alterations?” 
Key findings: 
 The model enables global health research related dialogue among five departments and 
agencies in a structured and focused manner that would likely not otherwise be 
possible. 
 Roles and responsibilities of all parties need to be clarified. 
 Leading practices indicate: 
o Clarity of an Initiative and the policy and research that it supports 
should be clearly established and agreed upon by all members/ 
committees/ boards within that Initiative, including the process for 
obtaining funding from partners and the use of those funds. 
o Performance metrics/ frameworks should be developed to monitor 
progress across all areas of an initiative including research projects and 
internal management performance.  
o Consideration of all avenues/partnerships/collaborations can provide 
many advantages. 
o The steering committee needs to have the right mix of members in order 
to be able to provide strong oversight and direction. 
 
A. Perceptions of Interviewed Key informants 
Through the conduct of focused interviews with a cross-section of key informants, as 
outlined in the Review scope and approach section of this report, the following key themes 
emerged concerning perceptions surrounding GHRI as a model. 
 The effectiveness of the model has varied over time largely as a result of the 
individuals who have been involved – the people involved in GHRI since its inception 
have been defined as both a strength and a weakness with the key strength being the 
knowledge and experience of and with GHRI and the weakness being limitations 
surrounding new ideas and approaches. 
 The model enables global health research related dialogue among five agencies in a 
structured and focused manner that would likely not otherwise be possible. This said, it 
was recognized by some that this forum may not be leveraged to its fullest, that the 
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coming forward from GHRI to influence global health and global health research 
policy. 
 The model has positively contributed to and facilitated the launch of such initiatives as 
Teasdale-Corti Research Partnership Program that some believe would otherwise not 
have been launched and/or been as successful. By way of contrast, some interviewed 
key informants have suggested that if GHRI were to no longer exist, agencies and 
departments would simply establish bi-lateral arrangements to fund global health 
research. 
 It has been suggested that there would be merit in revisiting the MOU every three to 
five years and asking each partner agency to confirm its commitment to GHRI by 
presenting a road map of what it intends to invest and/or do to contribute to the success 
of GHRI and the advancement of global health research. 
 There is a perception among some interviewed parties that while the model is valid in 
concept and has delivered value, the roles and responsibilities of the five partner 
agencies as they pertain to the GHRI and those of the Secretariat and Steering 
Committee need to be clarified and perhaps strengthened and/or streamlined.  
 It was suggested by some interviewed parties that consideration should be given to 
expanding the partnership model to include Grand Challenges as a means of facilitating 
the achievement of collaboration (where appropriate)..  
 GHRI and the partnership model enable Canadian agencies to coordinate their efforts 
with others in global health research internationally. 
There were also opinions voiced through the attendees at the 2009 Teasdale-Corti Team 
Meeting “there is a role for the GHRI to act something akin to an NGO advocating for a 
more inclusive, integrative and a broader conception of global health research.”21  This was 
also mentioned by a few researchers. 
 
B. Comparative Models 
As part of this review, KPMG conducted a comparative analysis with three relevant 
comparator organizations. This analysis was conducted to review the characteristics of 
these other programs/ initiatives, that share similarities to various elements of the GHRI, in 
order to identify possible lessons learned or better practices that GHRI could incorporate as 
possible improvements to their organization. These three comparator organizations were: 
 
 World Health Organization – Special Program for Research and Training in Tropical 
Diseases (WHO-TDR); 
 European and Developing Countries Clinical Trials Partnership (EDCTP); and  
 The Research Council of Norway (RCN) – Global Health Vaccination Research 
(GLOBVAC). 
 
The findings from the review of these organizations are detailed below, including insights 
gained, that could be applicable for program improvements for GHRI. Detailed summaries 
for each of these organizations can be found in Appendix B. 
                                                     
21 Post-meeting report, Global Health Research Initiative, 2009 Teasdale-Corti Team Meeting, Cairo, Egypt, 
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Organization Program/ Initiative Description 
• World Health Organization – 
Special Program for Research 




 Overview - This is a Special Programme executed by 
the WHO and sponsored by the UNICEF, UN 
Development Programme, the World Bank and WHO. It 
was established in 1975, this programme is focused on 
research and training in tropical diseases aimed at 
coordinating global efforts to combat major diseases of 
the poor and disadvantaged. Three main strategic 
directions are: stewardship, which consists of 
harmonized global research on infectious diseases of 
poor populations; empowerment, which is the support to 
researchers and public health professionals from disease 
endemic countries (DECs); and research on neglected 
priority needs, which facilitates new research, applying 
research and increase access to research. 
 Policy and Research Priorities - Research is focused 
on support (on neglected priority needs for disease 
control) for countries where diseases are prevalent and 
that fosters, innovation for product discovery and 
development, research on development and evaluation of 
interventions in real-life settings, and research to 
increase access to interventions. For empowerment the 
emphasis is placed on individual researchers and on 
systems that will sustain health research and its utility in 
DECs. For stewardship, a platform has been created for 
stakeholders to set priorities and harmonize their 
research on diseases of poverty. There are nine lines of 
research focus. 
 Funding – Receive funding from WHO, UN, World 
Bank, and voluntary contributions from donors.  
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Organization Program/ Initiative Description 
• European and Developing 
Countries Clinical Trials 
Partnership (EDCTP) 
 
 Overview – Created in 2003 in responses to health 
crisis caused by three main poverty-related diseases of 
HIV/AIDS, malaria and tuberculosis. The partnership 
includes 14 participating European Union member 
states plus Norway and Switzerland. Their aim is to 
accelerate the development of new or improved drugs, 
vaccines and microbicides against HIV/AIDS, malaria 
and tuberculosis, with a focus on phase II and III 
clinical trials in sub-Saharan Africa. 
 Policy and Research Priorities – The partnerships 
primary focus is to accelerate HIV research, and to 
develop research capacity in Africa. The five main 
types of grants they fund are related to: integrated 
projects on HIV/Aids, malaria and tuberculosis; senior 
fellowships (develop capacity in sub-Saharan  African 
institutes, etc.); ethics and regulatory projects; 
networks of excellence (setup regional networks for 
mentorship, conduct epidemiological/ demographic 
studies and support less established institutions 
with additional expertise); and member states 
initiated projects (integration of projects and 
programmes that have been independently 
initiated/funded by member states). 
 Funding - Funding provided by European 
Commission and by member states and third-party co-
funding. The EU Commission contributed $200m 
initially with the expectation that additional funding 
by members would total $200m over time (there is no 
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Organization Program/ Initiative Description 
The Research Council of Norway 




 Overview – The Research Council is comprised of 
three research division (Science, Strategic Priorities, 
and Innovation), one division for administrative 
affairs, and an executive staff that reports to a Director 
General. RCN is responsible for enhancing Norway's 
knowledge base and for promoting basic and applied 
research and innovation (including encouraging 
international research cooperation). Three areas of 
focus are: advisor on research policy issues, research 
needs and national priorities; implement national 
research policy objectives; and to act as a meeting 
place for researchers, funders and users of research 
findings (including international research). The Global 
Health Strategy for the country is primarily set by the 
Ministry of Foreign Affairs and the Prime Minister’s 
Office. 
 Policy and Research Priorities – Global Health and 
Vaccination Research (GLOBVAC) is part of the 
Strategic Priorities division and consists of two 
subprograms on global health research and vaccination 
research under a joint programme board including: 
Vaccination Research which strengthens current 
knowledge and contribute to new vaccines with 
international partners.  Committed to the Global 
Alliance for Vaccines and Immunization; and Global 
Health Research which contributes to knowledge on 
poverty-related diseases. 
 Funding - RCN's total budget is 7,703 million NOK$ 
(this is approximately $1b Can$) approximately half 
of which is spent on research programmes. 
GLOBVAC receives about $10m Can$ in budget of 
which one quarter goes to global research and three 
quarters goes to vaccination research. Funding is 
provided by several ministries including Ministry of 
Foreign Affairs (for development aid), Ministry of 
Health, and the Ministry of Research. 
 
Issues/ Observations:   
 
 WHO suggested that there needs to be a “convening power” to steer direction of policy 
setting and establish focus for an Initiative. They also suggested that it may be difficult 
to establish a global health policy without an overall foreign policy. 
 WHO reported that it can be problematic to balance the needs of the funders of 
research with the needs of the Board-approved research. There can also some tension/ 
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 European and Developing Countries Clinical Trials Partnership (EDCTP) has 
experienced some problems in receiving member contribution funding and now want 
to get countries to provide more upfront funding to the Partnership. There have been 
issues in working with countries that receive development funding for research as 
sometimes this funding comes with “strings attached” (e.g., how/ where to spend 
money, etc.). 
 The Research Council of Norway (RCN) is able to adjust their funding models in order 
to accommodate different countries, groups, and/ or research endeavours (e.g., 
allowing for private funding, etc.). Partnerships in funding with other organizations/ 
countries allow for Norwegian scientists to obtain larger grants/ funds and can 
complete larger scale global projects. 
 For their involvement with EDCTP, the RCN would like to improve the matched 
funding model which has been inconsistent with the member countries participating 
within the EDCTP (different countries have contributed inconsistently). 
 
Insights Gained:  
  
 There should be a clear mandate and direction set for a global health initiative and this 
should likely be a subset of a larger overall foreign policy. 
 Clarity of an Initiative and the policy and research that it supports should be clearly 
established and agreed upon by all members/ committees/ boards within that Initiative. 
 The process for obtaining funding from participant members of an Initiative, as well as, 
how funds can be utilized to support research projects should be formalized and agreed 
upon by all members of an Initiative in order to avoid future issues with funding and 
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Diseases                
(WHO-TDR) 
 
 Performance Metrics/ Indicators – WHO-TDR recently 
developed a performance framework in order to monitor progress 
of their programme (including metrics/ indicators, monitoring, 
evaluation plan). There are 11 key program results, with 29 key 
performance indicators (KPIs) that are monitored including: 











 Performance Metrics/ Indicators - The following measures are 
monitored on a monthly basis and updated quarterly on the 
EDCTP website (as well, annual reporting provides for further 
accountability): 
- Grants - value of grants signed; number of clinical trials 
approved; capacity building activities in Africa; and contract 
negotiation period. 
- Partnerships - African countries involved; African institutions 
involved; African project coordinators; and countries 
collaborating in projects. 
- Co-funding/donors - annual MS co-funding. 
- Governance – grants; other expenditures; EDCTP expenditures 












 Performance Metrics/ Indicators – Researchers prepare an 
annual report for each research project that they are involved in. 
They also sometimes produce scientific reports on research 
progress in the interim. The Board will occasionally do site visits 
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Issues/ Observations:   
 
 It appears that each of the three comparator organizations monitors performance of 
their programmes/ initiatives in a slightly different manner (e.g., KPIs (for grants 
signed, specific country involvement, management performance, etc.), annual reports, 
etc. ).  For some, this has been guided by the development of more formal performance 
frameworks. In all comparator organizations, they reported that they are satisfied with 
how they monitor performance and all felt that their programmes/ initiatives were 
making valuable contributions to their specific fields of research. 
 
Insights Gained:   
 
 Performance metrics/ frameworks should be developed that can appropriately monitor 
the progress of an Initiative. Performance metrics should include different areas of 
measurement in order to assess fully the whole performance of an Initiative (e.g., 
including progress on research projects, number of grants awarded, internal 
management performance, etc.). 
 


















 Agreements/ MOUs – WHO-TDR does not have any formal 
frameworks across the organizations that they work with as this 
would be too complicated to do. With some organizations, they 
have do MOUs in place but this varies dependent upon the 
organization. 
 Collaborative Relationships – WHO-TDR has partnerships/ 
collaborations with all levels of government, private/ public 
partnerships, industry, academia, research institutions, and non-
government organizations.  They also belong to a group called 
Essence for Health Research which provides a collaborative 
framework between funding agencies to scale up research 
capacity.  
 Governance Structures - WHO-TDR is governed by three 
bodies, including: Joint Coordinating Board which coordinates the 
interest and responsibilities of the Committees and makes final 
decisions (the Board was also recently responsible for approving 
the newly developed vision/ strategy for the organization); 
Standing Committee which reviews action plans and makes 
proposals to the Board; and the Scientific and Technical Advisory 
Committee which reviews and recommends priorities. 
 Roles & Responsibilities – WHO-TDR is structured by business 
lines. Specific research roles and responsibilities vary by 
organizations they are involved with (i.e. individual researchers, 
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 Agreements/ MOUs - Members must belong to the European 
Economic Interest Group (EEIG) which is a legal entity (and is 
more formal than an MOU). The Partnership was established 
under Article 169 of the European Treaty. 
 Collaborative Relationships –Partnerships/ collaborations 
include other European countries/ Norway/ Switzerland/ Africa, 
and other third-party collaborators (pharmaceutical companies, 
product development partners, Bill & Melinda Gates Foundation, 
etc.). All funded projects must include at least two European 
countries and/ or an African institution. Each country varies 
slightly on how they structure and fund projects, but each country 
also tries to fund their own researchers primarily. It can be a 
challenge for the EDCTP to match money to researchers to the 
different countries. They reported that they have been successful 
in gaining greater confidence in the work of African researchers. 
 Governance Structures - The legal entity is the European 
Economic Interest Group (EEIG), which each member state 
belongs to, and which consists of: the General Assembly (GA) 
which is the governing body with representatives from member 
states (the GA is also the primary decision maker in regards to 
policy and strategy setting); and the Secretariat (includes 26 staff) 
which is the executive body overseeing day-to-day management. 
External to the EEIG are: the Partnership Board (PB) (includes 9 
staff) which is the scientific independent expert panel that 
develops the strategic plan; the Developing Countries 
Coordinating Committee (DCCC) with representatives of African 
scientists who provide input and commitment of the African 
countries and researchers; and the High Representative which is 
appointed by General Assembly to raise visibility and represent 
EDCTP.  
 Roles & Responsibilities - For project selection, applications are 
assessed for eligibility by a Project Officer. Eligible applications 
are reviewed by an independent Scientific Review Committee and 
they also make suggestions. The Partnership Board passes on their 
recommendations through the Secretariat, who prepares a report 
of the recommendations, and the General Assembly makes a final 
decision. There are a total of five Project Offices who oversee the 
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 Agreements/ MOUs - GLOBVAC has a bilateral agreement with 
India for initiating projects together and to match funding on 
projects. 
 Collaborative Relationships – All projects must involve 
Norwegian institutions with other international partners. The 
research network includes: the Norwegian Forum for Global 
Health which promotes global health research with an emphasis 
on strengthening the capacity of Norwegian institutions and 
partners in low and middle income countries; the Department of 
Biotechnology which is a collaborative effort between India and 
RCN; and the European and Developing Countries Clinical Trials 
Partnership (EDCTP). 
 Governance Structures - The structure consists of: the Executive 
Board which is the highest authority of RCN (and consists of 
seven members and two deputies); Division Research Boards are 
comprised of one board for each research division and are chaired 
by a member of the Executive Board; there are Programme 
Boards which are appointed for each research programme (7-10 
people, which consists of external scientists, representatives from 
funding agencies, etc.); and the Division for Strategic Priorities 
which identifies and assesses national research needs. 
Improvements noted for the future include a pre-ranking of 
research proposals in order to assist the Boards in making 
decisions of which projects to fund. 
 Roles & Responsibilities - Roles are fairly clear on research 
projects. Contracts are established for each project and there is a 
project manager that is accountable to the RCN for status/ 
progress updates, etc. Researchers applying for grant money need 
to be part of a Norwegian institute/ organization. 
 
 
Issues/ Observations:   
 
 WHO made some recent changes and introduced new rules as NGOs were not well 
represented on their Board/ Committees. 
 WHO belong to a group called Essence for Health Research which provides a 
collaborative framework between funding agencies to scale up research capacity. This 
enables the Program to more effectively participate and work with other outside 
funding agencies.  
 For governance, the European and Developing Countries Clinical Trials Partnership 
(EDCTP) reported that for the General Assembly it is important to have the “right” 
people, those that have political clout in their home countries, in order to more 
definitively and quickly be able to acquire funds/ support commitments as needed. It is 
also important to have equal country representation on the Assembly in order to obtain 
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 The EDCTP also reported that there is a need to have very good coordination and 
oversight in order to bring together multiple countries in an effective manner for 
research projects. 
 The Research Council of Norway (RCN) reported that they can cover a wide scope of 
research projects and with minimal administrative staff. As they frequently sponsor 
conferences, the RCN is able to bring together groups of scientists which enable 
collaborative research across countries and organizations.  
 The RCN has currently established joint working groups with India which is better 
enabling their working relationships with that country. 
 
Insights Gained:   
 
 Consideration of all avenues/partnerships/collaborations available to help scale up 
funding capacity provides advantages to funders and researchers and the targeted 
sector. 
 The steering committee or group that has overall oversight of an Initiative, needs to 
have the right mix of members in order to be able to provide strong oversight, to be 
able to provides balanced, cohesive and focussed research direction overall, and to be 
able to represent/ balance the needs and interests of their originating jurisdictions. 
 Individual group or country specifications and/ or requirements can be built into 
research agreements, even when involving multiple jurisdictions, in order to ensure 
knowledge/ research translation is retained and transferred back to the individual’s 
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VI. Contrast with past GHRI 
evaluation studies 
Question #3: “What progress has been made since 2006?”   
This question is addressed as a separate chapter where a broader view of progress since 
2006 is presented, drawing on data elements and findings presented throughout the report. 
Key findings: 
 GHRI has been able to sustain its positive influences such as its good reputation, 
impact to global health research community, and increased awareness of global health 
research benefits among partners. 
 Little progress has been made in addressing noted areas for improvement.  A majority 
of the limitations noted in 2006 still exist.   
 
Two external reviews were undertaken in 2006 that documented strengths and areas for 
improvement for the GHRI.  The first study was an Organizational Assessment22 
conducted in May 2006.  The second study, A Global Health Research Initiative Review23 
was conducted in September of 2006.  Both reviews focused on the extent to which the 
GHRI was meeting its objectives. 
We have mapped the current findings analysis presented throughout the report against the 
strengths and opportunities identified from the 2006 studies.  This current study has found 
that most of the strengths noted by the external reviews undertaken in 2006 still exist and 
support these earlier findings.  The GHRI has been successful in maintaining these positive 
aspects.  The following table compares the findings: 
Strengths – 2006 Strengths – Current Review 
 Good reputation and profile 
 Effective mechanism for assembling 
funds 
 Raising awareness of global health 
research among all its partners 
 Good enabler of health research 
 Driven positive changes within the 
partners own organizational culture in 
 Applies “whole of government” 
approach, enhanced Canadian image 
on global stage 
 Pooled and leveraged funding of 
partners is effective and efficient 
 Catalyst for influencing visibility and 
attention to global health research 
within partner departments/agency, 
                                                     
22 An Organizational Assessment of the Global Health Research Initiative (GHRI), Sussex Circle, May 30, 
2006 
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relation to global health research 
 Good working relationships among the 
partners 
 Synergies have been created among the 
partners 
 Substantial success notably in capacity 
building 
Canada and abroad 
 Unique concept/model —the 
research being funded is otherwise 
unlikely to occur 
 Strong implementation team within 
the Secretariat going beyond typical 
Canadian research funding 
relationships. 
 Research projects are producing 
impacts 
 
However, the current review also finds some of the same areas for improvement identified 
in 2006 still exist.  There are some cases where efforts have been undertaken to address 
some of the opportunities raised by the 2006 reviews (i.e., GHRI has established a formal 
governance framework as of December 2009, formal steering committee procedures, a 
communications strategy, etc.), it does not appear these undertakings have been sufficient.  
The areas for improvement are compared below.   
Areas for Improvement – 2006 Findings – Current Review 
 A strengthened management and 
governance structure 
 Improved governance -- clearly separate 
strategic vs. operational functions and 
decision-making 
 Roles/responsibilities/value 
contributions of all partners and the 
Secretariat not fully understood or 
communicated 
 
 An enhanced role for the Secretariat – 
both resource wise and in terms of its 
capacity and decision-making ability 
 Secretariat could take on role of 
“knowledge broker”  
 The need for clearer definition by partner 
organizations of desired outcomes and 
performance targets in global health 
research 
 Develop clear performance indicators 
and accountability framework for the 
initiative 
 Unclear outcome expectations at 
Initiative level 
 
 The need for a strategic and operational 
plan that is reviewed/updated on a 
regular basis 
 The need for a clear focus, clear 
priorities/a common vision 
 Approved Strategic plan not in place, 
common priorities not yet defined 
(although there is a process underway) 
 Ad hoc funding 
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not balanced (i.e., need to increase 
focus on knowledge translation) 
 
 The need for an enhanced profile among 
the partner agencies, with the Agency 
Heads and with other organizations in 
Canada and internationally 
 Visibility within partner organizations 
is desired / needed, particularly at 
senior levels 
 Limited partnership building with other 
potential partner organizations 
nationally/internationally as well as 
synergistic programs within the 
partnership 
 The need to streamline exchanges of 
information among the five partners 
 Improved communication/knowledge 
sharing among partners 
 Simplification and/or standardization of 
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V. Conclusions and options for 
consideration 
Overall, the relevance and continued need for the GHRI remains strong. GHRI has 
contributed to putting Canada “on the map” in the area of global health research.  In order 
to remain relevant and sustainable opportunities exist to enhance GHRI’s relevance as well 
as its effectiveness and impacts.  In this section we summarize the data and analysis 
presented throughout the report in the form of key overarching Strengths, Weaknesses, 
Opportunities and Threats (SWOT) and then present options for consideration regarding 
the continuation and enhancement of GHRI. 
Key Strengths, Weaknesses, Opportunities and Threats 
Findings presented throughout the report have been complied into a summary of key 
Strengths, Weaknesses, Opportunities and Threats (SWOT) chart for a high level reference 
to GHRI’s position. 
    
 






 Unique concept/model —the research being funded is 
otherwise unlikely to occur
 Strong implementation team within the Secretariat going 
beyond typical Canadian research funding relationships.
 Catalyst for influencing visibility and attention to global health 
research within partner departments/agency, Canada and abroad
 Applies “ whole of government”  approach, enhanced Canadian 
image on global stage
 Pooled and leveraged funding of partners is effective and 
efficient





 Improved governance --clearly separate strategic vs. operational 
functions
 Increase and strengthen linkages/partnerships with other 
national/international organizations and synergistic programs 
within the partnership
 Improved communication/knowledge sharing among partners
 Secretariat could take on role of “ knowledge broker”  
 More focused development of GHRI “ niche”  areas (strategic 
planning, common priority setting)
 Identification of champion/true sponsor at executive level for 
each partner
 Clearly identify and communicate role of all partners and the 
Secretariat
 Simplification and/or standardization of administrative 
requirements between partners
 Further tap into Canadian expertise – scientific & policy
 Develop clear accountability framework
 Strategic plan not in place, common priorities not defined
 Ad hoc funding
 Limited partnership building with other potential partner 
organizations nationally/internationally as well as synergistic 
programs within the partnership
 Visibility within partner organizations is wanting, particularly at 
senior levels. 
 Emphasis on all three key activity areas is not balanced (i.e., 
need more focus on knowledge translation)
 Unclear outcome expectations at Initiative level
 Roles/responsibilities/value contributions of all partners and the 
Secretariat not fully understood or communicated
 Changes in government direction/priorities, economic climate
 Absence of GOC global health research strategy
 Ambiguous executive commitment and lack of recognition for 
value provided
 Expanding Canadian programs in global health research areas 
(e.g., Grand Challenges)
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Options for consideration 
Overall, it appears that GHRI is making progress in its stated strategic areas and the 
research projects supported through the Initiative are producing impacts.  It is also clear 
that researchers themselves and the Canadian global health research landscape would be 
negatively impacted should GHRI not continue.  Not renewing the Initiative could increase 
the risk of partners perhaps working at cross-purpose and a gap would be created in the 
global health systems research area. In effect, this is not seen to be a practical option at this 
time – unless of course an alternative mechanism or set of mechanisms was established to 
enable the progress made to date via GHRI to be leveraged and furthered through some 
other means.  Consideration has been given by some interviewed key informants regarding 
the possibility of similar initiatives and progress being made possible via bilateral 
agreements. While this may be the case, some interviewed internal and external key 
informants believe this would diminish the impacts to be made and would weaken 
Canada’s position/image internationally as being integrated in its global health research 
efforts.   
This said, however, it is clear based on the summary of findings and the international 
comparative review presented in the previous section of this report, that status quo is not a 
viable option either.  This is because there are some very fundamental areas that still 
requiring solidification, for example, a common understanding among partners as to what 
each partner brings to the table (including committed funding), the establishment of 
common priorities and what outcomes the GHRI is aiming to achieve.  There are also other 
areas that could be pursued now that GHRI has matured as an organization.  The 
exploration of strategic relationships with external organizations and the upcoming 
opportunity to make further use of research and performance indicators now that the 
projects are further along in their work plans are a few examples.  Opportunities do exist 
for the partners to enhance the GHRI.   
Some key informants felt consideration could be given to establishing the GHRI as a “true” 
horizontal initiative with a separate program budget.  According to Treasury Board, a 
horizontal initiative is an initiative in which partners from two or more organizations have 
established a formal funding agreement (e.g., Memorandum to Cabinet, Treasury Board 
Submission, federal/provincial agreement) to work toward the achievement of shared 
outcomes. The Office of the Auditor General (OAG 2005)24 recognizes that horizontal 
initiatives are generally a reflection that an issue is complex and can be dealt with most 
effectively by coordinated actions across departments of government.  This definition 
certainly fits with the GHRI however, with the transformation considerations noted below, 
GHRI should be able to achieve the benefits of such coordinated efforts without the 
administration and energy required to establish such a formal program. 
 
                                                     
24 Office of the Auditor General (2005), Matters of Special Importance – 2005, Chapter 4, “Managing 
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Enhance GHRI through transformation 
As a result of the information gathered and insight gained through documentation review 
and key informant interviews regarding the current relevance, performance, results, 
governance and model surrounding GHRI, it has become apparent that opportunity does 
exist to enhance the future value, performance, effectiveness, and impact of GHRI through 
modest yet meaningful transformation.   
It is believed that the transformation considerations presented below are within GHRI’s 
ability and control to implement provided the Secretariat and Steering Committee share a 
common vision on the desired change and maintain a shared commitment to planning, 
implementing, and sustaining the change.  Buy-in and commitment from all partner 
organizations will be essential for success. 
The planning and execution of the suggested change will require focus and dedication on 
the part of the Secretariat. To reduce the impact the effort will have on existing resources 
and minimize the degree of disruption on current Secretariat operations, consideration 
should be given to securing a resource for a defined period of time to work with the 
Secretariat and Steering Committee to plan, design, and implement the transformative 
change.  This individual could be seconded from one of the partner organizations or be 
secured via contract from the consulting community.  
Key transformation considerations include, but may not be limited to, the following: 
1 Clearer and more deliberate alignment of partner departmental/agency priorities and 
GHRI’s mission and priorities with the focus being on how GHRI can and will assist 
partner departments/agencies fulfill and/or enable fulfillment of their mandates and 
priorities.  
2 Formalization of a GHRI strategic plan complete with such key aspects as: vision; 
mission; values; strategic priorities/directions; strategic outcomes to be achieved; and 
action plans for each strategic priority/direction.25 
3 Formation of well defined strategic alliances with organizations and/or initiatives 
outside of the five partner departments/agencies which may be synergistic to what 
GHRI is striving to achieve.   Explore all avenues for collaboration with other 
Canadian and/or international organizations, private/ public partnerships, industry, 
academia, research institutions, and non-government organizations.  This practice, 
supported by the International Review and the key informant interviews, identifies 
benefits to scaling-up funding capacity which in turn provides advantages to funders, 
researchers and the targeted sector.  Such alliances should be clearly defined and 
agreed to by all parties and should include at a minimum:  intent of the alliance; 
degree and type of collaboration/coordination; specific and measurable strategic 
outcomes to be achieved; role and obligations of all parties in realizing defined 
strategic outcomes; and an agreed to process for measuring and reporting on results 
achieved and/or issues encountered. 
4 Clear articulation, documentation and agreement on what each partner organization’s 
contribution will be to the partnership and Initiative.  This should include specific, 
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measurable, achievable, relevant, and time-bound actions and contributions.  
Consideration should be given to both monetary and non-monetary contributions as 
both may be needed and of value.    
5 Renewal of the existing MOU to include more detailed articulation of: 1) why each 
of the five partner organizations is in the partnership, i.e., clear articulation of how 
GHRI participation will support and/or enable achievement of departmental/agency 
mandates and priorities; and 2) what meaningful and measurable contribution each 
partner organization will make to the GHRI partnership.  
6 Renewal of the GHRI management and governance regime so as to strengthen the 
value derived from and better delineate between the roles, accountabilities, and 
responsibilities of the Secretariat versus those of the Steering Committee.  Leading 
practices gleaned from the international comparator organizations and mentioned by 
key informant interviews lead to a requisite review of this area.  In so doing, 
consideration should be given to: 
- Examining the current focus and activities of the current governing body, i.e., 
the Steering Committee, to determine which areas of focus, activities and/or 
decisions made are more operational and/or tactical in nature and, therefore 
could/should be delegated to the Secretariat thus positioning the Steering 
Committee to focus exclusively on matters of strategic direction in 
collaboration with the Secretariat and provision of oversight to the Initiative. 
 
- Examining the membership of the existing Steering Committee and determine 
if the composition is optimal.  This could/should include consideration of 
such key aspects as: the seniority of each member, within their respective 
organizations, to provide strategic direction and oversight for GHRI; the  
level of authority and accountability he/she has within his/her home 
department/agency to make recommendations and decisions concerning 
GHRI; his/her ability to raise the visibility and awareness of GHRI within 
their home organization; and the relevance of each member’s position and 
organizational placement within their home department/agency and alignment 
of organization unit mandate and priorities and those of GHRI.  Strong 
oversight is critical to being able to provide balanced, cohesive and focussed 
direction and being able to represent/ balance the needs and interests of all 
partners and other interested parties and/or strategic alliances.   
 
- Considering the establishment of a two tiered governance structure whereby 
an Executive Strategic Advisory Committee is created and attended by 
partner department/agency ADMs and VPs. This could help elevate the 
awareness, interest and understanding of GHRI within and across all partner 
organizations and would potentially bring additional strategic insight and 
advice to GHRI thus potentially strengthening the alignment with 
departmental/agency priorities, GHRI relevance, and value to be derived 
through the Initiative. As well, it could help drive increased awareness and 
potential involvement on the part of Heads of Agency.  To manage the time 
demand this would place on members, consideration should be given to 
quarterly or semi-annual meetings.   Efforts would also have to be taken to 
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Committee and that of Steering Committee which could be rebranded as the 
Governance Committee. 
 
- Considering the inclusion of ex-officio members on the Executive Strategic 
Advisory Committee and/or Steering Committee/Governance Committee.  
Such members could be individuals from organizations outside of the existing 
partnership which are or may be synergistic.  This could include 
representatives from organizations with whom GHRI forms strategic alliances 
as suggested above.  This would establish a link with such organizations 
which may result in future and mutually beneficial collaborations and/or 
expansion of the reach and impact that can be made by GHRI. To limit the 
time burden on ex-officio members and raise the value GHRI will receive 
through their involvement, it is suggested that consideration be given to what 
discussions/type of discussions these individuals would be asked to 
participate in. For example, it may be only those meetings where strategic 
direction, priorities, collaborations, research programs are being discussed. 
 
7 Exploration of how GHRI via the partnership and Secretariat can be positioned 
beyond the role of ‘implementer’ to also be that of ‘a catalyst’ for forward thinking 
on matters pertaining to global health research and Canada’s involvement in terms of 
knowledge creation, capacity building and/or knowledge translation, and ‘knowledge 
broker’ between and among Initiative partners, strategic alliances, and other 
interested parties both domestically and internationally. As a starting point, this 
could include bringing key stakeholders together, facilitating and ‘holding the pen’ 
on the development of an integrated Government of Canada vision and strategy for 
global health research. 
8 Renewal of how GHRI documents contributions being made over time, what and 
how outcomes have been/will be achieved, and how these factors as well as overall 
progress and impacts will be monitored and reported on and to whom.  Within this 
context, consideration should be given to making use of existing tools, drawing on 
advantages of proven methods (i.e., leverage partner department experiences) and 
from the International Review, include different areas of measurement to fully assess 
performance of the whole Initiative (e.g., progress on research projects, as well as 
internal management performance, impacts to partners, etc.)  Each partner must see 
itself within the framework of outputs and outcomes/impacts.   This will help enable 
more focused and consistent measurement of GHRI performance.   
How GHRI wishes to pursue the above recommended transformation considerations should 
be explored and decided up jointly by the Secretariat, Steering Committee and Heads of 
Agency.  It is recommended that this be incorporated into or aligned with the planned 
upcoming Strategic Planning initiative. Further, it is recommended that consideration be 
given to engaging an independent and experienced facilitator to lead stakeholders through 
the process in a robust and systematic manner.  This will be important to help ensure the 
right questions get asked – including the most difficult and sensitive ones, the right people 
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Review of the Global Health Research Initiative 
Other departmental/agency representatives Interview Guide 
A. Relevance 
1. Is there a clear link between the activities performed by GHRI and the global health policy 
goals, priorities and concerns of your department/agency?  
2. Has the GHRI influenced your department’s/agency’s approaches to global health research in 
any way? 
3. How does your department/agency assess the value of GHRI work and to what extent are these 
value expectations satisfied (or expected to be satisfied in future)? 
4. To what degree do the GHRI activities complement or duplicate any other global health 
research initiatives within your department/agency? Within Canada?  Internationally? 
5. What effect does this have on the progress of meeting your department’s/agency’s global health 
policy goals, priorities and concerns? 
6. Do you view the GHRI as applying a “whole of government” approach?  If yes, what aspects 
stand out your mind?  If no, what is it lacking?  How might GHRI be able to change this?   
7. Are there other models/mechanisms/strategies that could be considered instead of GHRI?  What 
are/would be the pros and cons of each of these alternatives compared to GHRI? 
8. What are the anticipated future needs for global health research?  How can GHRI contribute to 
their achievement? 
B. Partnership 
9. How has the overarching GHRI MOU and partnership composition worked? (i.e., commitment 
and engagement) 
10. What benefits or efficiencies have been achieved through the GHRI partnership?   
11. What types of challenges are, or have been, encountered with the efficiency or effectiveness of 
the GHRI partnership? 
12. Does the GHRI partnership provide value added that would not be possible if the partners acted 
independently in this area?  
13. Are there opportunities to further strengthen the partnership?  If so, please explain what may be 
done. 
C. Governance, management and delivery 
14. Are the right governance/management mechanisms in place?  How effective are they? 
15. Are there opportunities to further strengthen governance, management and delivery elements?  
If so, please explain what may be done. 
D. Progress and Impacts 
16. To what extent are the activities of GHRI on track to achieve intended impacts in each of the 
three areas of activity?  What have been the factors for success or reasons for not being on 
track?  (Please provide supporting evidence or examples where possible.) 
17. What methods are used by GHRI to communicate results?  What are your views regarding the 
effectiveness of these methods? 
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18. Would the same results have been achieved in the absence of GHRI? 
E. Lessons learned 
19. What factors (both internal and external) affect GHRI’s performance?  Please discuss both 
those that facilitate success, and those that inhibit it. 
20. Are any refinements to the GHRI needed to facilitate the attainment of its objectives?  If yes, 
please describe the changes needed. 
21. Do you have any other comments? 
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Review of the Global Health Research Initiative 
Stakeholders Interview Guide 
A. Context 
1. Please briefly describe your position and relationship with GHRI. 
B. Relevance 
2. How relevant/important is this program to your organization?   
3. What national Canadian global health research approaches and strategies exist?  Has GHRI 
participated and effectively contributed to these approaches and strategies?  How? 
4. Are there opportunities for GHRI to increase its participation in this area? How? 
5. Has GHRI established appropriate collaborative relationships with its stakeholders? 
5.1. What mechanisms have been used to establish the relationships (e.g., involved in planning 
and/or participating in research projects)?  Are they effective? 
5.2. Are there opportunities to establish linkages or relationships with other organizations? 
6. To what degree do the GHRI activities complement or duplicate any other global health 
research initiatives within Canada?  Internationally? 
7. What effect does this have on the progress of meeting Canada’s global health policy goals, 
priorities and concerns? 
8. Do you view the GHRI as applying a “whole of government” approach?  If yes, what aspects 
stand out your mind?  If no, what is it lacking?  How might GHRI be able to change this?   
9. Are there other models/mechanisms/strategies that could be considered instead of GHRI?  What 
are/would be the pros and cons of each of these alternatives compared to GHRI? 
10. What are the anticipated future needs for global health research?  How can GHRI contribute to 
their achievement? 
11. Does the GHRI partnership provide added value that would not be possible if the partners acted 
independently in this area?  
C. Progress and Impacts 
12. Does GHRI have the potential to generate significant impacts in each of its three areas of 
activity? 
• Knowledge Creation:  strengthening global health research in Canada and in low and 
middle-income countries 
• Capacity Building:  Building research capacity to deal with global health challenges 
• Knowledge Translation:  Strengthening the capacity to use global health research results 
13. Would the same potential for results be achieved in the absence of GHRI? 
14. How does this compare with what was available prior to the existence of GHRI?  How does this 
compare to what is offered internationally? 
15. What factors (both internal and external) affect GHRI’s performance?  Please discuss both 
those that facilitate success, and those that inhibit it. 
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D. Lessons learned 
16. In summary, what would you say are the major advantages of the GHRI model to the federal 
government, the GHRI partners and the low and middle-income countries? 
17. And what disadvantages or weaknesses of the GHRI model should also be taken into account? 
18. What do you see for the future of GHRI? 
19. Do you have any other comments? 
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Review of the Global Health Research Initiative 
Researchers Interview Guide 
A. Context 
1. Please briefly describe your position and relationship with GHRI. 
B. Relevance 
2. How relevant/important is GHRI to your overall research program?   
3. To what degree do the GHRI activities complement or duplicate any other global health 
research initiatives within Canada?  Within your home country?  Internationally? 
4. Do you view the GHRI as applying a “whole of government” approach?  If yes, what aspects 
stand out your mind?  If no, what is it lacking?  How might GHRI be able to change this?   
5. Are there other models/mechanisms/strategies that could be considered instead of GHRI?  What 
are/would be the pros and cons of each of these alternatives compared to GHRI? 
C. Progress and Impacts 
6. Has or does your GHRI project have the potential to generate significant impacts in any of the 
three GHRI areas of activity?: 
• Knowledge Creation:  strengthening global health research in Canada and in low and 
middle-income countries 
• Capacity Building:  Building research capacity to deal with global health challenges 
• Knowledge Translation:  Strengthening the capacity to use global health research results 
7. Please describe the impacts that you consider the most significant and why they are important 
(e.g., important users and uses). 
8. Would the same potential for results be achieved in the absence of GHRI? 
9. In the absence of GHRI, how likely is it that your GHRI-supported research project(s) would 
have been supported at roughly the same level by some other funding source (e.g., one of the 
federal granting councils, a foundation, and some other international collaboration)?   




Not at all 
likely 
Don’t know 
      
10. What factors (both internal and external) affect your project’s performance?  Please discuss 
both those that facilitate success, and those that inhibit it. 
D. Lessons learned 
11. In summary, what would you say are the major advantages of the GHRI model to the Canadian 
federal government, the GHRI partners and the low and middle-income countries? 
12. And what disadvantages or weaknesses of the GHRI model should also be taken into account? 
13. Is GHRI needed in the future?  Why? 
14. Do you have any other comments? 
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Review of the Global Health Research Initiative 
Steering Committee Interview Guide 
A. Context 
1. Please describe the nature of your role and your involvement with GHRI. 
B. Relevance 
2. What current federal government global health policy goals, priorities and concerns does the 
GHRI contribute to?   
3. Is there a clear link between the activities performed by GHRI and the global health policy 
goals, priorities and concerns of your department/agency?   
4. Has the GHRI influenced your department’s/agency’s approaches to global health research in 
any way?  If yes, how?  If not, why? 
5. How does your organization assess the value of GHRI work and to what extent are these value 
expectations satisfied (or expected to be satisfied in future)? 
6. To what degree do the GHRI activities complement or duplicate any other global health 
research initiatives within your department/agency? Within Canada?  Internationally? 
7. What effect does this have on the progress of meeting partner global health policy goals, 
priorities and concerns? 
8. Are there other models/mechanisms/strategies that could be considered instead of GHRI?  What 
are/would be the pros and cons of each of these alternatives compared to GHRI? 
9. What are the anticipated future needs for global health research?  How can GHRI contribute to 
their achievement? 
C. Partnership 
10. How has the overarching GHRI MOU and partnership composition worked? (i.e., commitment 
and engagement).  How would you characterize the nature of this relationship? 
11. What benefits or efficiencies have been achieved through the GHRI partnership?   
12. What types of challenges are, or have been, encountered with the efficiency or effectiveness of 
the GHRI partnership? 
13. Does the GHRI partnership provide added value that would not be possible if the partners acted 
independently in this area?  
14. Are there opportunities to further strengthen the partnership?  If so, please explain what may be 
done. 
D. Governance, management and delivery 
15. Where does accountability for GHRI sit organizationally within your department/agency?  
Please briefly describe the other portfolio components and provide a breakdown of spending if 
possible. 
16. How are the following elements incorporated into the GHRI governance/management regime 
and how effective are they? 
a) Clear goals and objectives 
b) Clear management structure and decision-making processes 
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c) Mechanisms for setting overall GHRI priorities 
d) Mechanisms to ensure that budget allocation to GHRI programs is consistent with these 
priorities 
e) Communication and coordination mechanisms and processes 
f) Mechanisms for ensuring adequate input and control by all departments and agencies 
involved 
g) Mechanisms for program/project selection and funding 
h) Appropriate reporting and accountability mechanisms 
i) Delivery process sufficiently flexible to respond to changing needs, priorities and external 
influences 
17. To what extent does the GHRI Secretariat have the appropriate authorities to carry out its 
mandate?  How effective has it been? 
18. What types of contributions does your department/agency supply to GHRI (funding only, in-
kind service)?  How does your department/agency decide on contribution levels?  Who is 
involved in these decisions? 
19. Are there opportunities to further strengthen governance, management and delivery elements?  
If so, please explain what may be done. 
E. Progress and Impacts 
20. To what extent are the activities of GHRI on track to achieve intended impacts in each of the 
three areas of activity?  What have been the factors for success or reasons for not being on 
track?  (Please provide supporting evidence or examples where possible.) 
• Knowledge Creation:  strengthening global health research in Canada and in low and 
middle-income countries 
• Capacity Building:  Building research capacity to deal with global health challenges 
• Knowledge Translation:  Strengthening the capacity to use global health research 
results 
21. What influence (or anticipated effect) have these activities had: 
• On low and middle-income countries? 
• On partner departments and agencies? 
• In Canada generally? 
22. Would the same results have been achieved in the absence of GHRI? 
23. How are the GHRI’s results against these activity areas and their impacts tracked and reported?   
• To internal stakeholders (steering committee, Deputies & Heads of Agency, grant 
recipients and potential applicants) 
• To external stakeholders (parliamentarians, national and international health research 
organizations, other decision makers)? 
24. What factors (both internal and external) affect GHRI’s performance?  Please discuss both 
those that facilitate success, and those that inhibit it. 
25. Are any refinements to the GHRI needed to facilitate the attainment of its objectives?  If yes, 
please describe the changes needed. 
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F. Lessons learned 
26. In summary, what would you say are the major advantages of the GHRI model to the federal 
government, the GHRI partners and the low and middle-income countries? 
27. What disadvantages or weaknesses of the GHRI model should also be taken into account? 
28. What do you see for the future of GHRI? 
29. Do you have any other comments? 
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GHRI Operational Benchmarking of  
Global Health Research Initiatives 
 
Template for Information Regarding Specific Organizations or Initiatives 
Organization/Initiative Name: World Health Organization (WHO) - TDR 
 
Organization Attribute Description 
History • A programme for Research and Training in 
Tropical Diseases aimed at coordinating 
global efforts to combat major diseases of 
the poor and disadvantaged.  Established in 
1975. 
Mandate and objectives "An effective global research effort on 
infectious diseases of poverty, in which disease 
endemic countries play a pivotal role" 
Vision and ten year strategy outline three main 
strategic directions: 
• Stewardship – harmonized global research 
on infectious diseases of poor populations 
• Empowerment – support to researchers and 
public health professionals from disease 
endemic countries (DECs) 
• Research on neglected priority needs – 
facilitate new research, applying research 
and increase access to research 
Legal structure (e.g., a Branch or Ministry of 
government, an independent agency funded by 
government, a non-profit corporation funded 
by various sources, a consortium, etc.) 
• A Special Programme executed by the 
WHO and sponsored by the UNICEF, UN 
Development Programme, the World Bank 
and WHO 
Funding of the organization/initiative (sources 
and amounts, note: this is different from the 
funding of research projects). 
• Receives voluntary contributions from 
donors, for FY 10/11 a budget of US$ 121 
million is projected 
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Organization Attribute Description 
Governance (overall direction, such as a Board 
of Directors; mechanisms for the involvement 
of funding organizations; mechanisms for the 
involvement of stakeholders; mechanisms for 
expert advisory input) 
Govern by three bodies 
• Joint Coordinating Board – coordinate the 
interest and responsibilities of the 
Committees and make final decision. 
• Standing Committee – review action plan 
and make proposal to the Board 
• Scientific and Technical Advisory 
Committee – review and recommend 
priorities 
• Out contact:  Gary Aslanyan is Manager of 
Portfolio Policy & Development 
Global health policy priorities (country 
strategy and overarching priorities) 
Research – support (on neglected priority needs 
for disease control) countries where diseases 
are prevalent that fosters: 
• Innovation for product discovery and 
development 
• Research on development and evaluation of 
interventions in real-life settings 
• Research to increase access to 
interventions. 
Empowerment – place emphasis not only on 
individual researchers but on systems that will 
sustain health research and its utility in DECs. 
Stewardship – create a platform for 
stakeholders to set priorities and harmonize 
their research on diseases of poverty 
Research focus and objectives (primary areas 
of R&D undertaken or supported; intended 
impacts) 
Created nine lines for  research: 
• Lead discovery for drugs – facilitate & 
support discovery of new drugs for 
infectious tropical diseases (focusing on 8 
diseases) through networks & partnerships 
between pharmaceutical companies, 
academia and DEC institutions 
• Innovation research in DECs – foster the 
discovery & development of novel drugs, 
diagnostic tests and other products 
• Vector control interventions – develop & 
evaluate improved and innovative vector 
control methods for the prevention of 
neglected diseases (e.g., malaria, dengue, 
human African trypansomiasis and Chagas 
disease) 
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Organization Attribute Description 
 
• Drug development for helminths/NTDs – 
progress candidate drugs into development; 
generate evidence of efficacy and safety; 
and determine field safety and effectiveness 
of registered drugs and optimize their use 
• Quality-assured diagnostics – promote & 
facilitate research on the development, 
evaluation and introduction of diagnostic 
tests for infectious diseases of poverty 
appropriate for use in developing country 
settings 
• Evidence for treatment of TB/HIV – 
generate evidence for optimized treatment 
and case management for all TB patients, 
including those with HIV or additional co-
morbid diseases 
• Animalarial policy/access – develop 
strategies for improved access to effective 
treatment for malaria and other childhood 
fevers at all levels of the health system with 
the aim at reducing childhood mortality 
• Visceral leishmaniasis elimination – 
develop and validate innovative and 
efficient interventions and strategies for  the 
elimination of visceral leishmaniasis from 
the Indian Subcontinent 
• Community-based interventions – develop 
innovative, effective and efficient strategies 
for implementing community-bases 
interventions in poor populations 
Methods used for the identification of research 
priorities and programs 
See Governance above 
Partnering: Linkages to other organizations 
that perform research, or that use the results of 
the research (including government, university 
and academia) and if possible including the 
pros and cons of these partnerships. 
• Partnerships/collaboration with all levels of 
government private industry, academia, 
research institutions, non-government 
organizations to local clinics in remote 
areas.  
• Facilitate networks, create forums and 
gather lists of stakeholders, good practices, 
resources, discussions groups and scientist 
Methods used by the organization to report to 
its funding organizations • Annual progress reports and a final report must be completed using the official forms. 
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Organization Attribute Description 
Methods used by the research organization to 
report to stakeholders and the public (e.g., 
communications/outreach program) 
• Project publications allowed but must 
acknowledge TDR for funding. 
• Publications produced by TDR, journal 
articles from TDR-funded projects, 
educational CD-ROMs, videos and an 
image library  are available on-line  
Methods used for the identification of potential 
research projects (e.g., projects identified in 
planning exercises, proposal calls) 
• Provide grant opportunities post-graduate, 
academic graining, career development, 
short courses and research 
• Calls for collaborative research grants from 
corresponding lines of business posted on 
the website.  For first time applicants, 
recommend sending a brief outline of 
proposed research to get advice on 
relevance and implications. 
• No longer accepting DIF project proposals 
on an ad hoc basis, however will be 
establishing an Innovation fund for 
proposals outside the business lines 
priorities 
Methods used for project selection (review 
mechanisms and main criteria – e.g., how peer 
review is organized, whether factors other than 
scientific merit are considered [financial 
management, project management, etc.] and 
how) 
• Proposals reviewed by Scientific Steering 
Committee or Task Force, and makes 
recommendations to the Director, TDR. 
• Stipulations in the proposals on use of 
laboratory animals, human subjects. Blood 
samples, drugs and  medical devices.  Also, 
must submit document indicating national 
government approval, where required. 
Funding of research projects (Methods used for 
funding research projects (totally funded by 
organization, co-funding required, co-funding 
encouraged, etc.) 
• Funding awarded on a yearly basis and 
renewed for up to three years. 
• Signed Technical Services Agreement with 
WHO and the Institution responsible for the 
project. 
• Funding restricted to salary of Principal 
Investigator and costs for items such as 
overhead, administrative, equipment 
operation, other items  
Methods used to track and evaluate project 
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Key Interview Questions: 
 
 
1. What is your organization’s involvement in global health research?  Based on review of your 
web-site and available documentation, our understanding of your mandate and objectives (as 
it pertains to global health research) is as follows….. Is this correct? If not, please describe.  
2. In keeping with this mandate and objectives: 
• What are your country’s global health policy priorities?   
• How does your organization influence and/or enable achievement of these priorities?  
• What mechanisms do you have in place to track and report progress / impacts being made 
against these priorities? 
3. Within the context of fulfilling this global health research mandate, objectives and priorities: 
• How is your organization funded (e.g., annual program funding, project specific funding, 
combination of the two) and by whom? What is your budget for this fiscal? 
• How are priorities set and decisions made with respect to: a) identification and selection 
of research priorities, programs and projects; and 2) allocation of funding?  
• Do you work with other government and/or non-government organizations in a formal or 
informal partnership arrangement?  
- If so, which ones and for what purpose?  
- What are the roles and responsibilities of each organization in relation to global health 
research?  Is there a lead organization for global health research within your country 
and, if so, is it your organization or another?  How do the lead organization’s roles 
and responsibilities differ from those of the others involved as formal and/or informal 
partners?  
- Are the efforts of your organization (and these others) governed by a common global 
health research vision and/or set of strategic goals? Please explain. 
- Does a governance framework/structure exist to govern the roles and relationships 
between and among these organizations? If so, please describe. Is this governance 
framework/structure effective and would you recommend it to others? Why or why 
not. 
- Have other delivery and/or governance models been considered? If so, what and why? 
Are changes anticipated? 
 
4. Has your organization (independently and/or in collaboration with partnering organization) 
established highly effective practices (at a strategic, operational, tactical level) that you would 
recommend be considered by Canada? If so, what and why?   
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GHRI Operational Benchmarking of  
Global Health Research Initiatives 
 
Template for Information Regarding Specific Organizations or Initiatives 
Organization/Initiative Name: European and Developing Clinical Trials Partnership 
(EDCTP) 
 
Organization Attribute Description 
History • Created in 2003 in responses to health crisis 
caused by the three main poverty-related 
diseases of HIV/AIDS, malaria and 
tuberculosis 
• Includes 14 participating European Union 
member states plus Norway and 
Switzerland 
Mandate and objectives • "aim to accelerate the development of new 
or improved drugs, vaccines and 
microbicides against HIV/AIDS, malaria 
and tuberculosis, with a focus on Phase II 
and III clinical trials in sub-Saharan 
Africa" 
Legal structure (e.g., a Branch or Ministry of 
government, an independent agency funded by 
government, a non-profit corporation funded 
by various sources, a consortium, etc.) 
• Part of European Commission's Sixth 
Framework Programme for R&D 
Funding of the organization/initiative (sources 
and amounts, note: this is different from the 
funding of research projects). 
• Funding provided by European 
Commission and by member states and 
third-party co-funding (in the form of cash 
or in-kind/direct) 
• Total income since 2003 is € 221M or 
between € 10 to 80 M annually 
• Governance costs over € 600 K annually 
(include GA, PB, DCC and ENNP defined 
below) 
• Programme activities expenditures of about 
€ 3 to 4 M annually (staff salary, 
support costs, rental, etc.) 
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Organization Attribute Description 
Governance (overall direction, such as a Board 
of Directors; mechanisms for the involvement 
of funding organizations; mechanisms for the 
involvement of stakeholders; mechanisms for 
expert advisory input) 
European Economic Interest Group consist 
(EEIG) of: 
• Assembly (GA) – governing body with 
representatives from member states 
• Secretariat – executive body overseeing 
day-to-day management 
External to EEIG: 
• Partnership Board (PB) – scientific 
independent expert panel that develops the 
strategic plan 
• Developing Countries coordinating 
Committee (DCCC)– representatives of 
African scientist who provide input and 
commitment of the African countries and 
researchers 
• High Representative – appointed by 
Assembly to raise visibility/represent 
EDCTP 
• European Network of National 
Programmes (ENNP) - ? 
• Our Contact:  Dr. David Coles is Joint 
Programme Manager, works for the 
Secretariat 
Global health policy priorities (country 
strategy and overarching priorities) • Approach based on "Joint Programme Activities"; existing and/or ongoing 
research activities of two or more EU 
Member States working independently on 
the same area 
• Offer larger grants that focus on clinical 
trials as the core  and use networking and 
capacity development 
• Believes capacity development gives 
African researchers the opportunity to 'learn 
by doing' and networking create critical 
mass required for sustainability 
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Organization Attribute Description 
Research focus and objectives (primary areas 
of R&D undertaken or supported; intended 
impacts) 
Five main types of grants: 
• Integrated Projects on HIV/Aids, Malaria 
and Tuberculosis –clinical trials integrated 
with project management, networking and 
capacity development 
• Senior Fellowships – develop capacity in 
sub-Saharan  African institutes, promote 
career development in sub-Saharan African 
researchers and strengthen the capacity in 
to undertake clinical trial in the 3 diseases 
• Ethics and Regulatory Projects – strengthen 
local capacity in both Ethical Review and 
the National Regulatory framework in 
Africa 
• Networks of Excellence – setup regional 
networks for mentorship, conduct 
epidemiological/demographic studies and 
support less established institutions with 
additional expertise 
• Member States Initiated Projects -  
integration of projects and programmes that 
have been independently initiated/funded 
by member states 
Methods used for the identification of research 
priorities and programs • PB prepares proposals and recommendation to the Assembly on strategic needs and 
priorities, calls for project proposals, 
criteria for peer reviews, action plans and 
results of evaluation session 
• DCCC provides input of the strategy by 
aggregating and transmitting advice from 
scientists in developing countries to the PB 
• GA makes the final decision 
Partnering: Linkages to other organizations 
that perform research, or that use the results of 
the research (including government, university 
and academia) and if possible including the 
pros and cons of these partnerships. 
• Funded projects must include at least two 
European countries and/or African 
institution 
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Organization Attribute Description 
Methods used by the organization to report to 
its funding organizations • There is a Grant Agreement that must be signed 
• Project Coordinator will submit the clinical 
trial protocol, work plan and detailed 
budget to EDCTP 
• If applicable, official letters from all 
African and third parties involved 
• Project Coordinator must supply 'legal 
entity form' 
• EDCTP utilises a Performance Related 
Payment Scheme, in general, payments 
made after all Annual and Final Reports 
have been approved 
Methods used by the research organization to 
report to stakeholders and the public (e.g., 
communications/outreach program) 
• A list of grants awarded are published on 
EDCTP website and there is also an on-line 
database that contains a summary of all 
funded project 
Methods used for the identification of potential 
research projects (e.g., projects identified in 
planning exercises, proposal calls) 
• Call for proposals published on EDCTP 
website and relevant scientific journals 
• Applications submitted through institution 
from Africa or European Member state, 
involving a minimum of two European 
countries and/or African institution 
• Full proposal follow a template detailing 
objects and participants (sent via email) 
Methods used for project selection (review 
mechanisms and main criteria – e.g., how peer 
review is organized, whether factors other than 
scientific merit are considered [financial 
management, project management, etc.] and 
how) 
• Applications assessed for eligibility by 
Project Officer 
• Eligible applications reviewed by 
independent Scientific Review Committee 
and makes suggestions (Committee 
members identified by Project Office) 
• Partnership Board passes on their 
recommendations 
• Secretariat prepare a report of the 
recommendations 
• General Assembly make final decision 
• All proposal reviewed for Excellence, 
relevance, partnership and project 
management 
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Organization Attribute Description 
Funding of research projects (Methods used for 
funding research projects (totally funded by 
organization, co-funding required, co-funding 
encouraged, etc.) 
• European Member States should co-fund a 
minimum of 50% of estimate resources 
Methods used to track and evaluate project 
performance (performance measures) 
The following measures monitored on a 
monthly basis and updated quarterly on the 
EDCTP website: 
• Grants - 
 Value of grants signed(€) 
 # of clinical trials approved 
 Capacity building activities in Africa 
 Contract negotiation period (months) 
• Partnerships - 
 African countries involved 
 African institutions involved 
 African project coordinators 
 Countries collaborating in projects 
• Co-funding/donors - 
 Annual MS co-funding (€) 
• Governance - 
 Grants (€) 
 Other expenditures (€) 
 EDCTP expenditures in Africa (€) 
 EDCTP expenditures in Europe (€) 
 
 
Key Interview Questions: 
 
1. What is your organization’s involvement in global health research?  Based on review of your 
web-site and available documentation, our understanding of your mandate and objectives (as 
it pertains to global health research) is as follows….. Is this correct? If not, please describe.  
2. In keeping with this mandate and objectives: 
• What are your country’s global health policy priorities?   
• How does your organization influence and/or enable achievement of these priorities?  
• What mechanisms do you have in place to track and report progress / impacts being made 
against these priorities? 
3. Within the context of fulfilling this global health research mandate, objectives and priorities: 
• How is your organization funded (e.g., annual program funding, project specific funding, 
combination of the two) and by whom? What is your budget for this fiscal? 
• How are priorities set and decisions made with respect to: a) identification and selection 
of research priorities, programs and projects; and 2) allocation of funding?  
• Do you work with other government and/or non-government organizations in a formal or 
informal partnership arrangement?  
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- If so, which ones and for what purpose?  
- What are the roles and responsibilities of each organization in relation to global health 
research?  Is there a lead organization for global health research within your country 
and, if so, is it your organization or another?  How do the lead organization’s roles 
and responsibilities differ from those of the others involved as formal and/or informal 
partners?  
- Are the efforts of your organization (and these others) governed by a common global 
health research vision and/or set of strategic goals? Please explain. 
- Does a governance framework/structure exist to govern the roles and relationships 
between and among these organizations? If so, please describe. Is this governance 
framework/structure effective and would you recommend it to others? Why or why 
not. 
- Have other delivery and/or governance models been considered? If so, what and why? 
Are changes anticipated? 
 
4. Has your organization (independently and/or in collaboration with partnering organization) 
established highly effective practices (at a strategic, operational, tactical level) that you would 
recommend be considered by Canada? If so, what and why?   
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GHRI Operational Benchmarking of  
Global Health Research Initiatives 
 
Template for Information Regarding Specific Organizations or Initiatives 
Organization/Initiative Name: The Research Council of Norway (RCN) 
 
Organization Attribute Description 
History Research Council comprises of three research 
division (Science, Strategic Priorities, and 
Innovation), one division for administrative 
affairs and an executive staff that reports to a 
Director General.  Employs a staff of about 350 
people including international staff 
Mandate and objectives RCN is responsible for enhancing Norway's 
knowledge base and for promoting basic and 
applied research and innovation (including 
encouraging international research 
cooperation). 
Three areas of focus: 
• Advisor on research policy issues, research 
needs and national priorities 
• Implement national research policy 
objectives 
• Act as a meeting place for researchers, 
funders and users of research findings 
(including international research) 
Legal structure (e.g., a Branch or Ministry of 
government, an independent agency funded by 
government, a non-profit corporation funded 
by various sources, a consortium, etc.) 
• RCN is funded by several ministries, with 
the Ministry of Education and Research and 
the Ministry of Trade and Industry 
contributing 40% of its budget 
Funding of the organization/initiative (sources 
and amounts, note: this is different from the 
funding of research projects). 
• RCN's total budget is NOK 7,073 million, 
approximately half of which is spent on 
research programmes. 
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Organization Attribute Description 
Governance (overall direction, such as a Board 
of Directors; mechanisms for the involvement 
of funding organizations; mechanisms for the 
involvement of stakeholders; mechanisms for 
expert advisory input) 
• Executive Board – highest authority of 
RCN, consists of 7 members and two 
deputies 
• Division Research Boards – one board for 
each research division and chaired by a 
member of the Executive Board 
• Programme Boards – appointed for each 
Research Council's research programme 
• Division for Strategic Priorities – identifies 
and assess national research needs 
• Our Contact:  Karstein Maseide is a 
Senior Adviser, Global Health-and 
Vaccination Research 
Global health policy priorities (country 
strategy and overarching priorities) 
Norwegian research policy key points include: 
• R&D expenditure will be 3% of GDP 
• Focus on major global challenges relating 
to energy, climate, poverty and health 
• Advocate greater focus on 
internationalisation 
RCN global health: 
• Current initiative on vaccine research 
• Policy report for medical and health-related 
research indicates greater focus called for 
on epidemiological research, diagnosis, 
treatment and rehabilitation. 
• One of the goals is to promote international 
research cooperation and another goal is to 
further enhance the strongest medical and 
health-related research 
Research focus and objectives (primary areas 
of R&D undertaken or supported; intended 
impacts) 
• Global Health and Vaccination Research 
(GLOBVAC) – consist of two subprograms 
on global health research and vaccination 
research under a joint programme board 
• Vaccination Research – strengthen current 
knowledge and contribute to new vaccines 
with international partners.  Committed to 
the Global Alliance for Vaccines and 
Immunization. 
• Global Health Research – contribute to 
knowledge on poverty-related diseases 
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Organization Attribute Description 
Methods used for the identification of research 
priorities and programs • Annual conferences: 
• 2010 focus on the challenges of 
mitigating the impact on health from 
environmental changes 
• 2009 conference entitled "Meeting the 
challenges of the Millennium 
Development Goals and beyond – 
Health research and policy" 
Partnering: Linkages to other organizations 
that perform research, or that use the results of 
the research (including government, university 
and academia) and if possible including the 
pros and cons of these partnerships. 
• Global Health Research – projects based in 
Norwegian instates with international 
partners 
• Research network includes: 
• The Norwegian Forum for Global 
Health- promotes global health research 
with emphasis on strengthening the 
capacity of Norwegian institutions and 
partners in low and middle income 
countries 
• The Department of Biotechnology – 
collaborative effort between Ministry of 
S&T in India and RCN 
• European and Developing Countries 
Clinical Trials Partnership (EDCTP) – 
GLOBVAC contribute with 50 mill 
NOK co-funding available for EDCTP 
–calls on vaccination in 07/08 
Methods used by the organization to report to 
its funding organizations • Projects that receive funding from RCN must submit electronic progress and final 
reports according to their contract 
Methods used by the research organization to 
report to stakeholders and the public (e.g., 
communications/outreach program) 
• 62 projects listed on their website with a 
description and indication of project 
manager 
Methods used for the identification of potential 
research projects (e.g., projects identified in 
planning exercises, proposal calls) 
• Global Health Research – started up in 
2005 and has published two calls for 
proposals, currently there are no calls 
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Organization Attribute Description 
Methods used for project selection (review 
mechanisms and main criteria – e.g., how peer 
review is organized, whether factors other than 
scientific merit are considered [financial 
management, project management, etc.] and 
how) 
• RCN applications are assessed by at least 
two experts. 
• Applicant can provide feedback on outcome 
of assessment 
• Allocation decisions are made by the 
programme committee or research boards 
• There is an appeal/complaints process 
Funding of research projects (Methods used for 
funding research projects (totally funded by 
organization, co-funding required, co-funding 
encouraged, etc.) 
• RCN will normally fund between 25-50% 
of the total project costs for support to 
companies, but for small and medium size 
companies the ceiling may be raised an 
additional 10%. 
Separate budgets: 
• Vaccination Research – NOK 50 million 
yearly 
• Global Health Research – NOK 15 million 
yearly 
Methods used to track and evaluate project 
performance (performance measures) • In the midterm review it was recommended that GLOBVAC continue and be extended 
beyond 2011.  RCN has entered into 
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Key Interview Questions: 
 
 
1. What is your organization’s involvement in global health research?  Based on review of your 
web-site and available documentation, our understanding of your mandate and objectives (as 
it pertains to global health research) is as follows….. Is this correct? If not, please describe.  
2. In keeping with this mandate and objectives: 
• What are your country’s global health policy priorities?   
• How does your organization influence and/or enable achievement of these priorities?  
• What mechanisms do you have in place to track and report progress / impacts being made 
against these priorities? 
3. Within the context of fulfilling this global health research mandate, objectives and priorities: 
• How is your organization funded (e.g., annual program funding, project specific funding, 
combination of the two) and by whom? What is your budget for this fiscal? 
• How are priorities set and decisions made with respect to: a) identification and selection 
of research priorities, programs and projects; and 2) allocation of funding?  
• Do you work with other government and/or non-government organizations in a formal or 
informal partnership arrangement?  
- If so, which ones and for what purpose?  
- What are the roles and responsibilities of each organization in relation to global health 
research?  Is there a lead organization for global health research within your country 
and, if so, is it your organization or another?  How do the lead organization’s roles 
and responsibilities differ from those of the others involved as formal and/or informal 
partners?  
- Are the efforts of your organization (and these others) governed by a common global 
health research vision and/or set of strategic goals? Please explain. 
- Does a governance framework/structure exist to govern the roles and relationships 
between and among these organizations? If so, please describe. Is this governance 
framework/structure effective and would you recommend it to others? Why or why 
not. 
- Have other delivery and/or governance models been considered? If so, what and why? 
Are changes anticipated? 
 
4. Has your organization (independently and/or in collaboration with partnering organization) 
established highly effective practices (at a strategic, operational, tactical level) that you would 
recommend be considered by Canada? If so, what and why?   
 
